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Abstract
Analyzing combinatorial regulation of transcription in
mammalian cells
During development and dierentiation of an organism, accurate gene regulation
is central for cells to maintain and balance their dierentiation processes. Tran-
scriptional interactions between cis-acting DNA-elements such as promoters and
enhancers are the basis for precise and balanced transcriptional regulation. In this
thesis, proximal and distal regulatory regions upstream of all transcription start
sites were considered in silico to identify regulatory modules consisting of combina-
tions of transcription factors (TFs) with binding sites at promoters and enhancers.
Applying these modules to a broad variety of gene expression proles demonstrated
that the identied modules regulate gene expression during mouse embryonic de-
velopment and human stem cell dierentiation in a tissue- and temporal-specic
manner. Whereas tissue-specic regulation is mainly controlled by combinations of
TFs binding at promoters, the combination of TFs binding at promoters together
with TFs binding at the respective enhancers determines the regulation of tem-
poral progression during development. The identied regulatory modules showed
considerably good predictive power to discriminate genes being dierentially reg-
ulated at a specic time interval. In addition, TF binding sites are immanently
dierent for promoter and enhancer regions.
One example for combinatorial regulation of transcription in mammals is
cholesterol biosynthesis. Cholesterol biosynthesis is regulated by the family of
sterol regulatory element binding proteins (SREBPs) that control the expression
of genes involved in the uptake and synthesis of cholesterol and lipids. However,
SREBPs are weak transcriptional activators themselves and have been shown to
work in co-operation with other transcription factors such as Sp1 transcription fac-
tor (SP1) and nuclear transcription factor Y (NF-Y). Although the metabolism for
cholesterol biosynthesis is well described, it is assumed that many other proteins
contribute to cholesterol homeostasis and cholesterol mediated homeostasis of the
cell. In this thesis, an integrative approach was applied that allowed systematic
identication of potential SREBP target genes. Candidate genes were identied
by gene expression proling of sterol-depleted cells and in silico prediction of
SREBP, SP1, and NF-Y binding sites. With this, 99 putative SREBP target
genes were identied among which a major portion of genes (21 genes) known
to regulate cholesterol biosynthesis and 78 novel potential SREBP target genes
were retrieved. Ten of the putative novel 78 SREBP target genes were selected
for experimental validation and slc2a6, c17orf59, hes6, and tmem55b showed
reduced mRNA expression after SREBP knockdown, indicating a regulatory role
by SREBP in combination with SP1 and NF-Y.
Combinations of transcription factors are substantial to the understanding of
regulation of transcription and enhancer function, can yield generic insights into
tissue- and temporal regulation of gene expression, and can elucidate novel target
genes involved in a specic pathway.

Zusammenfassung
Analyse kombinatorischer Regulation der Transkription in
Saugetierzellen
Prazise Genregulation ist wahrend der Entwicklung und Dierenzierung eines Or-
ganismus auerst wichtig, um die notwendige Homeostase wahrend der Zellent-
wicklung und -dierenzierung zu ermoglichen. Dabei bilden Interaktionen zwischen
cis-wirkenden DNA-Elementen wie Promotern und Enhancern die Basis fur eine
abgestimmte Regulation der Transkription. In dieser Arbeit wurden proximale und
weiter entfernte Regionen stromaufwarts aller Transkriptionsstartpunkte in silico
betrachtet, um regulatorische Module vorherzusagen, die aus Transkriptionsfak-
torkombinationen mit Bindestellen an Promotern und Enhancern bestehen. Die
Anwendung auf verschiedene Genexpressionsprole zeigte eine gewebe- und zeits-
pezische Regulation der identizierten Module in der embryonischen Entwicklung
der Maus und in der menschlichen Stammzelldierenzierung. Zusatzlich zur gewe-
bespezischen Regulation von Transkriptionsfaktorkombinationen am Promoter
bestimmen Kombinationen von Transkriptionsfaktoren an Promotern und Enhan-
cern zeitspezische Regulation wahrend des Entwicklungsprozesses. Die identi-
zierten regulatorischen Module zeigten eine gute Vorhersagefahigkeit, dierenziell
exprimierte Gene unterschiedlicher Zeitpunkte zu unterscheiden. Auerdem wurde
gezeigt, dass Transkriptionsfaktorbindestellen unterschiedliche Eigenschaften an
Promoter- und Enhancerregionen aufzeigen.
Ein Beispiel fur kombinatorische Regulation der Transkription in Saugetier-
zellen ist die Cholesterinbiosynthese. Die Cholesterinbiosynthese wird durch die
SREBP (sterol regulatory element binding protein) Proteinfamilie kontrolliert, die
die Expression von Genen regulieren, die in der Aufnahme und Synthese von Cho-
lesterin und Lipiden involviert sind. SREBPs sind nur schwache transkriptionelle
Aktivatoren und kooperieren mit anderen Transkriptionsfaktoren wie SP1 (Sp1
transcription factor) und NF-Y (nuclear transcription factor Y). Obwohl der Me-
tabolismus der Cholesterinbiosynthese gut beschrieben ist, wird angenommen, dass
viele weitere noch unbekannte Proteine an der Cholesterinhomeostase der Zelle be-
teiligt sind. Daher wurde in dieser Arbeit ein integrativer Ansatz verfolgt, um neue
Zielgene von SREBP zu identizieren. Dazu wurden Genexpressionsprole von
sterol-depletierten Zellen mit in silico Vorhersagen von SREBP, SP1, und NF-Y
Bindestellen kombiniert. Insgesamt wurden 99 mogliche SREBP Zielgene identi-
ziert, von denen 21 Gene bereits im Zusammenhang mit Cholesterin beschrieben
wurden und 78 Gene potentiell neue SREBP Zielgene darstellen. Zehn der poten-
ziell neuen Zielgene wurden fur eine experimentelle Valdierung ausgewahlt, wovon
slc2a6, c17orf59, hes6, and tmem55b niedrigere mRNA Expression nach SREBP
Knockdowns zeigten und damit potentiell regulatorisch von SREBP abhangig sind.
Kombinationen von Transkriptionsfaktoren sind auerst wichtig, um sowohl
Regulationsmechanismen der Transkription als auch die Funktion von Enhancern
zu verstehen. Sie konnen neue Erkenntnisse uber die gewebe- und zeitspezische
Regulation der Genexpression bringen und die Identizierung neuer Zielgene in
bestimmten Prozessen ermoglichen.
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Chapter 1
Introduction
1.1 Motivation
There exist about 20,000-25,000 protein-coding genes in human [66]. How-
ever, the number of DNA-binding factors is estimated to be 1850 [179].
Multiple regulatory elements within promoters allow combinatorial control
of transcriptional regulation, which increases the potential number of expres-
sion proles notably [179]. Transcription factors (TFs) cooperate with other
regulatory co-factors and the complex combinations of multiple cooperative
interactions give the necessary specicity for spatio-temporal transcriptional
regulation [174]. The combinatorial and temporal binding of TFs is crucial
for metazoan development [310] and for the establishment of tissue specic
gene expression [229].
Specically in higher organisms, proximal versus distal regulation needs
to be well balanced [147]. Whereas promoters are proximal to transcription
start sites (TSS), enhancers can be quite distant from their target genes.
Transcription factors bound at an enhancer interact with co-activators and
transcription factors bound at the promoter. Hence, they increase the con-
centration of activators at promoters. The large distance between long-range
enhancers and proximal promoters can be overcome by chromatin loops,
bringing these elements in close proximity [118, 196]. Thus, enhancers can
increase the activity of a promoter considerably, even when located several
kilo bases away.
Promoter-enhancer interactions depend on regulatory factors binding at
promoter-proximal regions. In turn, these factors may recruit specic distal
enhancers [49, 267] depending on the combination of regulatory factors
at the proximal promoter [164]. Levine and Tjian [164] suggested that a
combination of dierent complexes are needed for a temporal- and tissue-
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specic regulation of cis-DNA elements, allowing a vast variety of distinct
gene expression patterns. One of the main challenges is now to understand
how dierent combinations of transcription factors establish gene expression
under specic conditions [179].
One example of combinatorial regulation in mammals is the transcrip-
tional regulation of cholesterol biosynthesis. Cholesterol biosynthesis in
mammals is regulated by the family of sterol regulatory element binding
proteins (SREBPs) that control the expression of genes involved in the
uptake and synthesis of cholesterol and lipids. However, SREBPs are weak
transcriptional activators themselves and work in co-operation with other
transcription factors such as Sp1 transcription factor (SP1) and nuclear
transcription factor Y (NF-Y) [72, 134, 234, 241]. Although the metabolism
for cholesterol biosynthesis is well described, it is assumed that many other
proteins contribute to cholesterol homeostasis and cholesterol mediated
homeostasis of the cell [121]. In addition, dysfunction of cholesterol has been
implicated in a number of diseases such as cardiac diseases, dementia, dia-
betes, and cancer [127, 185]. Furthermore, diseases caused by dysfunctional
cholesterol uptake and synthesis like Familial Hypercholesterolemia and
Niemann-Pick Disease Type C are poorly understood and open questions
remain concerning the regulation of cholesterol metabolism and molecular
interactions of known cholesterol-regulating factors [22].
The focus of this thesis is twofold. First, combinations of transcription
factors at promoter and enhancer regions were analyzed and immanent dif-
ferences of enhancers and promoters aecting the regulation of genes during
critical developmental stages of dierent tissues and cell types identied.
Dierentially expressed genes at specic time intervals of the development
of each analyzed tissue were associated to their regulating TFs. The system-
atic comparison of temporal and tissue specicity of TFs and combinations
of TFs binding at promoters and enhancers revealed a major role of the
combinations of TFs in promoter regions together with TFs in enhancer
regions for temporal specicity in development and dierentiation. Second,
an integrated approach was applied to identify novel putative SREBP target
genes by combining gene expression proling and in silico predictions of
binding sites for SREBP and its known co-factors SP1, NF-Y, and LXR.
This approach allowed the identication of 78 genes that have not yet been
described to be involved in cholesterol biosynthesis. We picked ten genes
for experimental validation out of which four genes showed lower mRNA
expression after knockdown of SREBP, indicating their regulatory role
depending on SREBP.
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1.1.1 Publications
The main work presented in this thesis is currently in review and the
manuscript is entitled \Enhancers regulate progression of development in
mammalian cells". A manuscript covering the second part of the thesis
(\Identication of novel putative SREBP target genes") is currently in
preparation. I was also involved in a publication \PathWave: discover-
ing patterns of dierentially regulated enzymes in metabolic pathways"
published in Bioinformatics [247].
1.1.2 Thesis outline
The rst chapter introduces the biological background, existing computa-
tional methods, and basic topics covered in this thesis. The focus lies on
transcriptional regulation in eukaryotes and the computational identication
of transcription factor binding sites. Additionally, basic concepts in machine
learning and network analysis are presented. In chapter 2, the methods
applied in this thesis are presented, specically the developed approach to
identify regulatory modules and successive analyses as well as the integrated
approach for the identication of novel putative SREBP target genes. Chap-
ter 3 depicts the results of this thesis and presents regulatory modules that
control gene expression during development and dierentiation in a time-
and tissue-specic manner as well as potential new SREBP target genes.
The results are discussed and an outlook is given in chapter 4.
1.2 Organization and regulation of eukaryotic
genomes
The genome, the complete set of information in the DNA of a cell or an
organism, not only encodes all genes, but also contains the information to
express these genes in a spatio-temporal manner [260]. The central dogma in
science regarding gene expression is that genes encode mRNA, which in turn
encodes proteins [285]. The genetic information is encoded in its deoxyri-
bonucleic acid (DNA) sequence. DNA is a large polymer composed of four
dierent nucleotide subunits, each consisting of a ve-carbon sugar (deoxyri-
bose) attached to a single phosphate group and a nitrogen-containing base.
The four dierent bases are called adenine (A), cytosine (C), guanine (G),
and thymine (T). These bases are connected via a sugar phosphate backbone
through the 3'-hydroxyl group of a sugar to the 5'-phosphate group of an-
other sugar. Therefore, one end of the DNA carries an unlinked hydroxyl
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Figure 1.1. From DNA to protein. Genetic information is passed from
DNA to RNA in a process called transcription and from RNA to protein in a
process called translation.
group to the 3' position on the sugar ring (3' end) and the other end carries
a free phosphate group at the 5' position on the sugar ring (5' end). It is
the order of the base pairs from its 5' end to its 3' end that encodes the ge-
netic information of a cell. Each DNA strand is paired with a complementary
DNA strand which are held together via hydrogen bonds formed between the
bases. This pairing is specic with an adenine forming two hydrogen bonds
with a thymine and a guanine forming three hydrogen bonds with a cytosine.
Chemical and structural features of the DNA chains force the DNA into the
typical DNA double helix, the predominant form in the cell. [3]
Genomes of higher eukaryotes can be up to several billion base pairs
long, e.g. the human genome has a length of around 3 billion base pairs [65].
Nowadays, a large number of genomes has been successfully sequenced and
the number of available DNA sequences is rapidly increasing due to new
high throughput sequencing techniques. The challenge now is to decipher
the genetic code embedded in the genomic sequence [65].
A large number of genes, information containing-elements of DNA that
determine characteristics of an organism by encoding functional cellular
components such as proteins [3], have been already identied. The se-
quence of a gene is used as a template to synthesize ribonucleic acid (RNA)
molecules in a process called transcription. RNA is chemically similar to
DNA but contains a sugar ribose instead of a deoxyribose and the base uracil
(U) instead of thymine. In addition, RNA is a single-stranded molecule.
The RNA molecule copied from protein-coding genes is called messenger
RNA (mRNA). It is used as a messenger molecule for the production of
proteins by being translated into a chain of amino acids. Genes can be
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separated into distinct protein-coding regions (exons) and intervening non-
coding regions (introns). The mRNA is formed by joining dierent exons
whereas introns get excised from the primary transcript. Alternative splicing
adds another layer of complexity of gene expression regulation by allowing
the incorporation of dierent exons from the same primary transcript [194].
Once the mRNA has been formed, a poly-A tail is added to the 3' end of
the mRNA and a cap structure is added to its 5' end. The mature mRNA
is then transported out of the nucleus into the cytosol where it is translated
into a protein, a long polymer chain of monomeric building blocks called
amino acids. [3] The information ow from DNA to proteins is shown in
Figure 1.1.
In higher eukaryotes, genes are embedded into large regions of non-coding
DNA, e.g. only 1-2% of the DNA encodes for genes while most of the genome
does not and has yet mostly unknown function [156]. It may be involved
in regulatory processes [65, 164, 181]. Identifying regulatory regions and in
particular transcription factor binding sites located many kilo bases away
from their corresponding genes in the vast stretches of non-coding DNA
remains a major challenge.
1.2.1 Measuring gene expression with microarrays
Expression microarrays allow the simultaneous measurement of transcription
levels for every known gene in an organism [142] and have been used to iden-
tify disease specic gene signatures (for cancer e.g. [62, 279, 294]). Most
microarray platforms are designed to address a specic set of questions in
a specic organism [117]. The term microarray analysis is usually used for
transcript analysis [117] and microarrays are commonly used to compare lev-
els of expression of genes from samples from two dierent tissues or at two
distinct experimental conditions (e.g. normal vs diseased tissue, treated vs
untreated samples) [41]. However, microarrays can also be used for geno-
typing, epigenetic studies, structural variation, splice-variant analysis, and
protein binding [117]. Although transcriptional proling is the most widely
used application, it focuses on a biological intermediate [117] with transcrip-
tion being the rst step in gene regulation. Still, the correlation between
mRNA and protein abundance in the cell is not straightforward [8, 56, 109].
Microarrays are glass slides with articially constructed grids of DNA [47].
One array can contain up to hundreds of thousands of spots which consist
of what are known as probe sequences. The probes can be single-stranded
cDNA (complementary DNA, the reverse transcribed product of mRNA)
and long oligonucleotides (60-70 bp) or short oligonucleotides (25 bp as
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with Aymetrix R arrays) [11]. There are other dierences between oligonu-
cleotide microarrays and spotted cDNA microarrays. Aymetrix R arrays
contain between 11 and 20 pairs of oligonucleotide probes per target RNA.
One of each pair is the reverse complement to an ideally unique 25mer in
the RNA and the other contains a single mutation [5]. In contrast, cDNA
microarrays contain a single probe for each target RNA and the two dierent
biological samples are represented by dierent colors. After hybridization,
each color is scanned separately and relative expression levels are achieved
by comparing the intensities [47]. For oligonucleotide microarrays, each mi-
croarray represents a single sample and provides an absolute measurement
level for each RNA molecule, whereas for cDNA microarrays each microar-
ray measures two samples and provides a relative measurement level for each
RNA molecule [47].
A microarray experiment involves a number of distinct stages. First, RNA
is extracted from biological samples, amplied and labeled with a uorescent
dye. It can then be hybridized to the arrays and the microarrays are pro-
cessed to get intensities by scanning the arrays [257]. Following, the target
quantity is measured indirectly by measuring the intensity of uorescence of
the spots on the array for each uorescent dye [5]. The raw data produced
by microarray experiments are monochrome images, that need to be trans-
formed into gene expression matrices. The intensity is read by a camera and
transformed into gray level values using image processing [61, 76, 244, 262].
In the end, one gets 4,000-50,000 measurements per biological sample [47].
Microarray analysis
Biological replicates are essential to estimate and reduce measurement vari-
ability and biological dierences between the cases [5]. However, technical
replicates estimate and reduce only eects of measurement variability and
are not required when making inferences about populations from samples [5].
To analyze dierentially expressed genes under two conditions, at least ve
biological cases per group should be analyzed but larger numbers are prefer-
able [215].
To make microarrays comparable and to reduce noise, the intensities must
be quality-controlled and normalized to adjust for dye-bias and for any sys-
tematic variation in the technology. Intra- and inter-microarray variations
can skew the interpretation of such expression data [47]. In addition, hy-
bridization images can contain artifacts, such as bubbles and scratches [245].
A rst quality assessment is done by a visual inspection of the images and
plots of the raw data [11]. So called MA-plots are commonly used to plot
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the log ratios M with
M = log2
R
G
(1.1)
against the average intensity values A with
A =
1
2
log2(R G) (1.2)
where R and G represent the intensity levels for a given spot. MA-plots give
a good impression of the distribution of the raw data. As most genes are not
expected to be dierentially expressed, the majority of points should lie in a
cloud around M = 0.
Results from individual experiments need to be normalized with respect
to each other to account for experimental variation in RNA amounts, specic
activity of probe labels, and standard handling errors [59] and is an impor-
tant step of the preprocessing of microarray data. Individual intensities are
adjusted to be able to make comparisons both within the array as well as be-
tween arrays in the experiment. These adjustments are necessary to remove
purely technical dierences that do not represent biological variation and to
be able to identify true dierentially expressed genes [11]. Normalization can
include the adjustment of the overall brightness of each scanned microarray
image [300], using expression levels of housekeeping genes [75] or assuming
that most genes are not dierentially expressed [309]. Various normalization
approaches have been developed [75, 122, 222, 256, 309]. After normalization
is completed, dierentially expressed genes or functional groups classifying
the samples into meaningful groups can be identied [47, 257].
The earliest approach to identify genes whose expression is signicantly
dierent between the two conditions is a simple fold-change criterion to
detect genes of interest. However, it is perceived as an inadequate test
statistic [190] as it does not incorporate variance. More sophisticated sta-
tistical tests achieve more reliable identication of dierentially expressed
genes [41]. Signicance has been evaluated in many dierent ways, including
parametric [274] and non-parametric tests [214], analysis of variance [139],
and many others [47]. Common statistics for dierential expression are the
t-statistic and its non-parametric counterpart the Wilcoxon statistics [11].
Another method to identify dierentially expressed genes is based on cal-
culating rank products which is similar to the fold-change but overcomes
its most signicant limitations [41]. It is based on the assumption that the
probability of gene being dierentially expressed increases with the number
of times a gene is dierentially expressed in replicate experiments.
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The rank product is dened as
RPg = (
kY
i=1
ri;g)
1
k (1.3)
where ri;g is the position of gene g in the list of genes in the ith replicate
sorted by decreasing fold change for an experiment examining n genes in
k replicates [41]. Signicance is then assessed by permuting the expression
values of the genes for each single array.
Testing thousand of genes of transcripts for dierential expression simul-
taneously produces a large amount of false-positives. This testing of many
hypotheses within a single study is called multiple testing and dierent mul-
tiple testing correction approaches have been developed [5]. One of the most
popular multiple testing corrections includes the Bonferroni correction [35]
where the p-value of each gene is multiplied with the total number of genes.
A less stringent correction is the Benjamini-Hochberg correction [26] where
the p-value of each gene is multiplied by the total number of all genes divided
by the rank of the p-value compared to all p-values.
An interesting development is the testing of groups of genes instead of
single genes where one is interested in a group-wise eect (e.g. [99, 247])
which leads to an increase of power [11]. These genes usually share common
features, such as all genes from a pathway.
1.2.2 Regulation of gene expression
Spatial and temporal expression of genes is crucial for development, dieren-
tiation, and all biological processes [179]. There exist various dierent mecha-
nisms to regulate eukaryotic gene expression at various steps, including tran-
scription, mRNA splicing and processing, transport, translation, stability,
post-translational modication of proteins, and degradation [179]. However,
transcription initiation is believed to be the most regulated step [179]. Tran-
scription is regulated by cis-regulatory elements, such as promoters and distal
regulatory elements, e.g. enhancers, silencers, insulators, and locus control
regions [179]. These elements contain recognition sites for trans-acting pro-
teins binding to these elements [158, 243] that either repress or enhance tran-
scription [179]. The genetic information encoded in the DNA of eukaryotic
genes requires the regulated synthesis of specic RNAs by molecular machines
called RNA polymerases. The protein-coding genes are transcribed by RNA
polymerase II [90, 243] and transcription initiation requires, in addition to
RNA polymerase II, the binding of regulatory elements and co-factors to cis-
regulatory sequences [239]. It is the interplay between promoters, proximal
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Figure 1.2. Overview of transcriptional regulatory elements in the
genome. The promoter is composed of a core and proximal promoter. Gen-
eral transcription factors bind to core promoter regions through recognition of
common elements such as TATA boxes and initiators (INR). Promoter activ-
ity can be increased by site-specic transcription factors binding to proximal
promoter regions. Distal regulatory elements can include enhancers, silencers,
insulators and locus control regions. Promoter activity can be further stimu-
lated by site-specic factors binding to enhancers. In contrast, transcriptional
activity can be repressed by transcription factors binding to silencers. En-
hancer blocking insulators ensure enhancer interaction with the promoter of
the right gene.
and distal regulatory elements as well as their binding factors and cofactors
that contribute to the precise nature of the transcriptional output of any pro-
moter [179]. Figure 1.2 gives an overview of all regulatory elements involved
in transcription.
Promoter Core and nearby proximal promoters are the basic elements
that regulate transcription [239]. They contain binding sites for transcrip-
tion factors and common sequence elements that recruit the general tran-
scriptional machinery to the transcription start site (TSS) [81] as well as ad-
ditional chromatin-modifying factors [81, 158]. The region around the TSS
is referred to as the core promoter and is approximately 100 bp in length.
It is sucient for directing transcription initiation by the basal transcrip-
tional machinery [158] and denes the position of the transcription initiation
site and direction of transcription [255]. It contains an AT-rich site called
the TATA box [158] which is located 25 to 30 bp upstream of the TSS in
higher eukaryotes [265] and serves as the binding site for the TATA-binding
protein (TBP) [158]. The core promoter can also contain an initiator ele-
ment (Inr) [254]. Factors binding to Inr may facilitate the recruitment of
the transcriptional machinery [50, 137]. Promoters in higher eukaryotes are
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highly diverse. Core promoters can contain either element, Inr or TATA box,
both elements or neither element [158]. Core promoters of many genes do not
contain any of the known core promoter elements [102] and TATA-containing
promoters are rather the exception than the rule [65]. So called null promot-
ers often have multiple TSS [96, 170] that are in close proximity to each other
[243] and most human genes have alternative promoters [52, 143] which are
thought to be used in dierent contexts and tissues. In mammals, promoters
containing a TATA box are usually associated with tissue- or context-specic
genes [248] and require a ner regulation [53]. However, the majority of hu-
man genes (80-90%) have promoters close to CpG islands [141], stretches of
DNA 500-2kb in length with high C+G content [179]. Methylation of these
islands is associated with transcriptional silencing and blocks transcription
factor binding to their recognition sequences [179]. Promoters containing
CpG islands are thought to be involved in the regulation of ubiquitously ex-
pressed genes [114]. The proximal promoter lies immediately upstream from
the core promoter (up to a few hundred bais pairs) and contains multiple
binding sites for activators [179]. However, the distinction between proximal
and core promoter elements may be blurred in mammals [206], as sequence-
specic TFs might also contribute to the positioning of RNA Polymerase II
at the TSS [187].
Enhancer Similar to promoters, enhancers contain binding sites for
transcription factors but can be located far upstream from the TSS [81].
An enhancer is sometimes also referred to as any regulatory element with
binding sites for sequence-specic transcription factors [13] but the term
is mostly used for distal regulatory regions. Enhancers usually contain
clusters of DNA-binding sites for more than one type of transcriptional
activators [13, 158]. They inuence transcription independent of their ori-
entation and distance from the TSS, which can be upstream (as great as
85 kb), downstream of the promoter in an intron, or even beyond the 3' end
of a gene [32]. Enhancers are highly modular and a single promoter can
be acted upon various enhancers in a time- and tissue-specic manner [15].
Enhancers can increase transcriptional activity indirectly through chromatin
remodeling or directly through interactions with the general transcriptional
machinery [32].
There exist several enhancer models. In one model, binding of multiple
transcriptional regulators to the enhancer can lead to the formation of en-
hanceosomes [158]. The stability and function of an enhanceosome is depen-
dent on the arrangement of binding sites, the interaction of the activators
and the addition of architectural proteins [51]. In contrast, the billboard
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enhancer model is more exible with independent interactions of each bind-
ing factor with the basal machinery and exact binding site locations are less
critical [14].
Interaction of enhancers with the promoter occur by looping out the in-
tervening DNA between these elements [179].
Silencer Silencers are similar to enhancers but repress promoter activity
in an orientation- and position-independent manner instead of enhancing
transcription [204]. Repressors binding to silencers can inhibit transcrip-
tion through dierent mechanisms, e.g. interfering with activator binding,
preventing recruitment of the transcriptional machinery, and modifying the
chromatin structure [81, 204]. Methylation of a CpG dinucleotide motif has
been implicated in silencing in higher eukaryotes [149].
Insulator Enhancer blocking insulators are negative regulatory elements
lying between an enhancer and the promoter [239]. They can also block genes
from being aected by the transcriptional activity of neighboring genes and
prevent spreading of repressive chromatin [179].
Locus control regions Similar to enhancers, locus control regions (LCRs)
contain multiple binding sites for activators [158]. Whereas enhancer func-
tion can be diminished by the chromatin structure of the site of integration,
LCRs can stimulate transcription independent of the chromatin structure
but are limited by orientation and distance [84]. LCRs consists of groups of
regulatory elements involved in regulating an entire gene cluster [179].
Chromatin structure To t DNA into the nucleus, DNA is packaged
into a nucleoprotein complex known as chromatin [158]. The repeating unit
of chromatin is the nucleosome which contains 146 bp of DNA wrapped
1.65 turns around an octamer of histone molecules [158]. Higher-order
chromatin structure is composed of nucleosomes coiled into chromatin
bers [312]. Histones can be modied in various ways, including acetylation,
methylation, and phosphorylation [239]. These modications can epige-
netically control the expression of genes by controlling the accessibility of
chromatin [239]. Transcriptionally active chromatin (euchromatin) contains
many sites which are hypersensitive to DNases open for transcription [104].
Nucleosomes can prevent transcription initiation by restricting access of
transcriptional regulators to the DNA [158]. Removing nucleosomes can
enhance binding of activators and the transcriptional machinery [151, 130].
The actual TSS region has been shown to be free of nucleosomes [17].
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Binding of general transcription factors to the core promoter results
usually just in low transcriptional activity. The basal machinery can be
dened as those factors that are essential for basal transcription in vitro
from an isolated core promoter [255]. Tissue-specic and developmentally
regulated expression of genes requires a ner tuning, and the recruitment
of additional transcriptional elements located in upstream, intronic, or
downstream regions [299]. Site-specic factors binding to the proximal pro-
moter can support the recruitment or stabilization of interactions of general
factors at the core promoter, thereby increasing transcriptional activity [81].
Binding of regulatory factors to distal enhancer regions and recruitment of
histone-modifying enzymes such as Swi/Snf and SAGA (PCAF) to promot-
ers [126, 218] can generate a more favorable environment for transcription
which leads to a further increase in promoter activity [81]. The general tran-
scriptional machinery includes subunits of RNA polymerases and complexes
such as TFIID [81] and co-activators. An RNA polymerase II-holoenzyme
consisting of general transcription factors and a multi protein complex called
the Srb/Mediator is recruited by transcriptional activators [175]. The media-
tor complex provides activator targets and can integrate multiple regulatory
signals [158]. RNA polymerase II has been shown to contain 10-12 subunits
with diverse functions including start site selection, transcriptional elon-
gation rates, and interactions with activators [10]. RNA polymerase II is
associated with elongation factors [232] and protein complexes involved in
RNA capping, polyadenylation and splicing [28].
Co-activators may support the action of activators by protein-protein
interactions with DNA-bound activators [258]. These co-activators can play
a crucial role in regulation and can switch activators to repressors [160].
Multiple copies of the same factor or dierent factors can act synergistically
to increase transcription greater than the sum of individual activity [179].
Transcriptional regulation is a balanced process of positive and nega-
tive regulators [158]. Transcriptional activators and repressors modify the
chromatin structure to make it accessible to the transcriptional machinery
and recruit the initiation apparatus to promoters [158]. The transcriptional
apparatus can be recruited in multiple steps or in a single step if already
fully assembled [158]. Activators can also increase the elongation rate for
polymerase by stimulating the rate of promoter escape, its processivity, or
facilitate reinitiation of transcription [305]. Repressors can compete with
activators for binding sites or can interact with components of the transcrip-
tional machinery and chromatin [204]. Transcription consists of a series of
steps, including promoter melting, clearance, and escape, before a fully func-
tional RNA polymerase II elongation complex is formed. After the formation
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Figure 1.3. Transcription initiation by RNA polymerase II. RNA
polymerase II and various general transcription factors (GTF), e.g. TFIID,
form the pre-initiation complex around the transcription start site. Other
regulatory proteins, such as Mediator, chromatin remodelers, coactivators, and
sequence-specic transcription factors (TFs), are involved in transcriptional
regulation.
of a stable transcription initiation complex (Figure 1.3), the promoter is
cleared and elongation is induced to produce an RNA transcript [158]. RNA
polymerase II is phosphorylated to switch from initiation to elongation and
cofactors associated with the polymerase are exchanged [158].
After primary transcripts are produced by RNA polymerase II, they are
modied at both ends and are subjected to splicing [158]. 5' end modi-
cation is crucial for further processing, localization, and translation [281].
5' ends are capped with a methylated guanosin triphosphate [158]. In con-
trast, 3' ends are cleaved and polyadenylated [158]. This modication is
essential for transcript termination, transport, translation, and stability of
the transcript [307]. mRNA is proofread and aberrant RNA molecules are
degraded [116]. Mature mRNA is then exported to the cytoplasm [198].
Regulatory factors located in promoter proximal regions do not always
activate or repress transcription in the classical sense but serve as tethering
elements recruiting distal enhancers to the core promoter [49]. It is possible
that some regulatory factors recruit some enhancers, while other combina-
tions recruit other enhancers [164]. Dierent complexes of regulatory ele-
ments are necessary for temporal- and tissue-specic regulation of distinct
cis-DNA elements [164]. These dierent complexes binding at promoter and
enhancer elements oer a variety of combinations of distinct gene expression
patterns [164].
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1.2.3 Transcription factors
Transcription factors can be described as proteins that regulate the produc-
tion of RNA in dierent modes of action [182]. They regulate the expression
of genes by binding to sequence-specic binding sites that can occur genome-
wide [182]. Transcription factors rarely work alone but cooperate with each
other either by direct interaction or through co-activators or co-repressors [81]
and transcription factor bindings sites were identied to cluster together to
regulate transcription cooperatively [29]. It is yet unknown what determines
the set of binding sites bound in a particular context but the inuence of
chromatin accessibility is assumed to play a major role [48].
There exist approximately 200-300 transcription factors that bind to core
promoter elements and 1400 sequence-specic transcription factors. Tran-
scription factors consist of two functional domains, a DNA-binding and
an activation domain that is crucial for the TF to stimulate transcription
[179, 192]. There exist various classes of transcription factors with more than
100 known DNA-binding domains and specic DNA binding sequences [179]
and approximately 12 to 15 structurally distinct DNA-binding domains are
known from eukaryotic TFs [112]. Grouping of TFs according to their bind-
ing domain can provide insights into their function, e.g. homeodomain con-
taining TFs are often involved in developmental processes [173]. The DNA-
binding domain can be composed of contiguous amino acids (e.g. home-
odomain, MADS box) or dispersed within the primary sequence (e.g. Zn-
ngers) [299]. Three types of TF domains account for 80% of the repertoire
in the human and mouse genome: the C2H2zinc-nger, homeodomain and
helix-loop-helix [103, 280].
The binding sequence is a rather short and degenerate sequence of 6-12 bp
which is described in a consensus sequence whereas the binding specicity
is dictated by just 4-6 bp [179]. Dierences in the binding sequence can
aect the strength of the activator binding which can have implications for
crucial situations such as embryonic development when transcription factors
are distributed in a concentration gradient [179]. Specic factors determine
the set of genes to be transcribed and are either ubiquitously expressed or
are rather tissue-specic [280].
Transcription factors can bind close or far away from regulated genes,
upstream, downstream or in the introns of the genes they regulate [45].
Transcription factors binding in close proximity to the TSS are thought to
stabilize general transcription factors at core promoter elements, whereas
transcription factors binding to distal regions of a gene induce interactions
between distal elements and the general transcriptional machinery bound
at the TSS [81]. The analysis of 1% of the human genome has shown
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that transcription factors binding primarily at proximal promoter regions
are rather the exception than the rule [65, 54, 55] as less than 10% of the
analyzed factors had the majority of their binding sites within 2.5kb of a
TSS [65], e.g. YY1 [114] and E2F1 [31]. Distal sites have been shown to
be involved in tissue-specic regulation [239]. Transcription factors binding
rather at distal positions include p53 [55], ER [54], NFB [178], CREBP [80],
and STAT1,2 [113]. The genomic distribution patterns of these factors re-
semble distal regulatory elements such as enhancers [114].
General transcription factors required for promoter binding by RNA poly-
merase II in vitro include TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH [211].
The mediator provides targets for transcriptional activators and by pass-
ing signals to RNA polymerase II and components of the initiation appara-
tus [158].
1.3 Identication of transcription factor
binding sites
One of the challenges in genomic research is the identication of all func-
tional elements, including those factors that regulate gene expression. The
identication of these elements will help to uncover mechanisms in various
diseases [179]. The availability of genome sequences of various organisms,
microarrays and the development of computational methods have facilitated
the identication of cis-regulatory sites on a genome-wide scale [52, 53, 55]
and allow the analysis of transcription factors under various conditions [202].
1.3.1 Experimental techniques
The identication of transcription factor binding sites using experimental
approaches is crucial for a better understanding of biological function of TFs,
for the analysis of tissue- and temporal-specic eects on gene expression
[164], and for an improvement of computational predictions [77].
If the regulatory factors are unknown, alterations of chromatin struc-
ture and experimental manipulation of dened DNA segments can lead to
the identication of the location of a functional element [77]. Direct mea-
surements of interactions of a regulatory factor with the DNA provide more
precise information when the TF involved has been identied [77].
Traditionally, TF binding specicity has been determined using footprint-
ing methods that identify the DNA region protected by a bound protein,
nitrocellulose binding assays, gel-shift analysis, or reporter constructs [45].
Several sequencing-based high-throughput methods on a genome-wide scale
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require the isolation of cDNAs, sequencing of their 5' ends and mapping of
these fragments to a genomic DNA sequence [243]. Chromosome confor-
mation capture can be used to identify interactions between chromosomal
regions such as regulatory elements to their corresponding transcript [301].
Reporter assays Reporter assays are the classical experimental approach
to characterize regulatory elements. The candidate transcriptional regulatory
element, a promoter, and a reporter gene are tested in vitro or in vivo in a
synthetic construct [138, 146] and the change in production of the reporter
protein in response to the candidate regulatory element is measured [77].
EMSA Electrophoretic mobility shift assay (EMSA) is a traditional
approach for the identication of interactions between DNA and pro-
teins [87, 93]. This 'gel-shift' assay can be used to verify the ability of a
protein to recognize and bind a target DNA sequence [77].
DNaseI hypersensitivity DNase hypersensitive sites, nucleosome-
depleted regions digested by DNAseI, are markers for functional regions in
non-coding sequences [57, 104]. DNase hypersensitivity assays map changes
in chromatin structure [77] and detect sites of open chromatin likely to con-
tain functional transcription factor binding sites by sequencing the anking
sites of DNaseI cleavage sites [111, 239].
ChIP Chromatin immunoprecipitation is one of the most powerful experi-
mental techniques for the in vivo mapping of DNA-associated proteins when
the regulatory factor is known [77, 153]. Binding sites for a specic TF
can be isolated by antibodies that recognize the specic TF bound to their
target DNA [239]. A large number of binding regions can be identied at
the same time in living cells [239]. This assay captures in vivo interactions
between DNA and a protein by cross-linking proteins to their DNA recogni-
tion site [77]. The cells are lyzed and DNA is fragmented into small pieces
followed by immunoprecipitation using a TF-specic antibody [77]. Rever-
sal of the cross-linking releases the DNA for subsequent detection by PCR
amplication [77]. ChIP is used to identify DNA-bound factors on a ge-
nomic scale by hybridizing DNA sequence segments to promoter or tiling
microarray (ChIP-chip) [233, 250]. The identied ChIP products can also be
identied by ultra-high-throughput sequencing (ChIP-seq) [21].
ChIP-chip High-throughput variations of the ChIP technique amplify all
genomic sequences with binding sites for the given protein [77]. These se-
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quence fragments are then hybridized to a genome-wide tiling or promoter
microarray [77, 153]. Whereas tiling arrays cover the whole genome se-
quence, promoter microarrays cover the upstream regions of the TSS for
every gene (1-10 kb) [142, 153]. One of the key issues is the identication
of the best binding sites among all identied potential sites which requires
computational methods [77]. In addition, the microarray design and probe
density dictates the ability to identify binding regions [239].
ChIP-Seq Chromatin-immunoprecipitated DNA can also be sequenced us-
ing massively parallel sequencing, often referred to as next-generation se-
quencing [153]. The sequence reads are mapped to a reference genome [153]
and a peak-nding algorithm is used to determine binding site locations [213].
Unfortunately, due to repetitive DNA sequences, not all sequence reads can
be mapped unambiguously [153]. ChIP-Seq has a ner resolution than ChIP-
chip in large genomes (25-200 bp compared to 200 bp) [153].
SELEX ChIP and subsequent motif discovery may miss binding sites due
to partial occupancy or low resolution [153]. The identication of all bind-
ing sites under all possible biological conditions for each TF remains also
elusive [153]. However, in vitro proteins bind to DNA probes regardless of
the condition [153]. Systematic evolution of ligands by exponential enrich-
ment (SELEX) [263] is a high-throughput approach to screen short, random
oligonucleotide probes for recognition by a specic protein in vitro [77]. This
way, short DNA sequences with a high anity to the transcription factor of
interest are selected from randomized short double-stranded DNAs from a
genome-wide library [208].
1.3.2 Computational approaches
A number of bioinformatics approaches have been developed for the identi-
cation of both known and unknown transcriptional regulatory elements [179].
Upstream sequences can be scanned for motifs of known transcription factor
binding sites extracted from databases such as TRANSFAC [183]. It is also
possible to analyze sets of coexpressed genes and identify common sequence
motifs in their upstream region [179] under the assumption that co-expressed
genes are also co-regulated [169]. If the set of genes is coexpressed, the expres-
sion might be mediated by common regulatory elements [284]. Coexpressed
genes can be identied by e.g. microarray expression experiments. These
sequences can not only be used to identify binding sites for known transcrip-
tion factors but also for the de novo identication of binding motifs which
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are overrepresented in the set of upstream sequences of the genes of interest.
Description of binding motifs are built from experimentally determined
transcription factor binding sites in DNA and can be used to form a consensus
sequence or a position weight matrix (PWM), also called position specic
score matrix (PSSM), [259] which can in turn be used to scan a putative
regulatory region for motif occurrences [284]. Consensus sequences are simple
strings over the 4-letter alphabet [A,C,G,T] that forms DNA sequences [107].
The degenerate IUPAC nucleic acid code [132] also describes variation in a
specic position [107]. However, degenerate consensus sequences contain
little information about the actual nucleotide frequencies at the dierent
positions of the binding prole [45]. Thus, PWMs or PSSMs are used to
describe the nucleotide preferences for a specic factor [45].
PWMs
To construct a PWM, identied binding sites are aligned and the distribution
of each base in each position of the binding motif is used as the weight in
the PWM (see Figure 1.4). Hence, the elements of a PWM describe the
likelihood of a nucleotide at a certain position [45]. The observed number
of occurrences of each nucleotide at each position is represented in a count
matrix [227]. This number is divided by the number of total sequences so all
rows sum up to one [227]. A constant is often added to the matrix to avoid
the occurrence of zero counts. This allows a minimal chance of a nucleotide at
that position to occur rather than no chance at all [227]. For computational
purposes the matrix is then transferred into a PWM using a logarithmic
scale [290]. The PWM is slid over a sequence and in each sequence window
a score is determined that captures the overlap between the sequence region
and the PWM [111, 227]. There are a number of ways to use the determined
score to decide if a match is an actual predicted binding site [111]. If the
score exceeds a pre-determined threshold, the match is counted as a hit
of the PWM at the identied sequence region [227]. A score threshold is
often chosen in a way that the probability of nding a false hit by chance
is at most 0.05 which limits false positive detections [227]. Rahmann and
colleagues [227] developed a method that also accounts for the probability
of detecting a true hit when there is a binding site present in the sequence
(called the power).
A drawback of PWMs is the assumption that each position in the binding
motif is independent towards the binding of the TF [27, 107], although this
has been proven wrong in a number of situations [46, 176].
TRANSFAC [183] and JASPAR [287] are two major databases for eukary-
otic PWMs [284]. Although these PWM libraries are incomplete, the search
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Figure 1.4. Representation of transcription factor binding sites.
A An example of six aligned sequences. B A position weight matrix for
the given sequences and the consensus sequence derived from the matrix. S
represents G or C. The score for each nucleotide at each position is obtained
from the observed occurrence of that nucleotide at the corresponding position
in the given sequences. C Sequence logo of the given sequences. The higher a
letter the higher the probability of that nucleotide at the given position.
for occurrences of known motifs is less complex than the de novo identi-
cation of motifs [273]. A major drawback of scanning long sequences using
PWMs is the inevitable large number of false positive hits due to the low
information content of the binding sites [284].
Furthermore, predicted binding sites may not be functional binding sites
and may not be bound in vivo due to various reasons such as the chro-
matin structure [45]. In addition to better motif descriptions, clustering of
binding sites, evolutionary conservation of binding sites, and enrichment of
regulatory sites in co-regulated genes can help to improve binding site pre-
dictions [283, 284].
Phylogenetic footprinting The term phylogenetic footprinting refers to
the identication of conserved regulatory patterns in orthologous sequences
using phylogenetic comparisons [45, 284]. The availability of a large number
of genome sequences has enabled the comparison among dierent organisms.
It is assumed that cis-regulatory elements are more conserved than non-
coding sequences [284] and that orthologous genes are regulated by the same
mechanisms in dierent species [290].
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cis-regulatory modules Transcriptional regulation occurs through the
combined action of multiple transcription factors [174]. Thus, transcrip-
tional regulatory sequences often comprise multiple binding sites for multiple
regulatory factors in close proximity to each other [169]. Elements with
a large number of binding sites are called cis-regulatory modules (CRM).
Clustering of transcription factor binding sites is often used for the iden-
tication of CRMs [284]. These clusters can contain multiple binding
site for the same TF (homotypic) or multiple binding sites for multiple
TFs (heterotypic) [288]. CRMs can also be identied in conserved sequences
when the sequences are aligned [284]. Searching for clusters of co-occurrences
of binding sites has been shown to increase prediction specicity without
loosing sensitivity [29].
Detection of CRMs can be performed following three dierent approaches
[169]. To identify CRMs in a specic and well-studied process, genome-wide
binding sites for a predetermined set of transcription factors are detected,
often using a combination of PWMs, e.g. [110, 228]. A second approach
identies regulatory elements in a set of co-expressed genes, e.g. [272, 278].
The last approach yields at identifying genome-wide binding sites for any
combination of transcription factors without any assumptions on a specic
set of TFs or any specic process. This approach is more general and
does not assume specic sets of transcription factors working cooperatively.
However, only a few methods have been developed to identify sets of in-
teracting transcription factors without prior knowledge on a genome-wide
scale. One example is PReMod [33] where statistically signicant clusters of
up to ve transcription factors were searched in whole-genome alignments.
The method is based on the assumption that regulatory regions consist
frequently of clusters of binding sites for a few dierent transcription factors
and that these clusters are more conserved than their anking intergenic
sequences. Transcription factor binding sites were predicted in the human
genome within a human-mouse-rat alignment block using vertebrate PWMs
obtained from TRANSFAC [183]. To reduce false positive hits, the devel-
oped scoring method favors simultaneous matches in all three species. In
a second step, clusters of putative transcription factor binding sites were
identied. For this, regions of at most 2 kilobases (kb) were determined
that were signicantly enriched with binding sites for one up to ve dierent
transcription factors.
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1.4 Regulation in development
Animal development is a fascinating process. Out of a single fertilized egg an
embryo develops and embryonic cells dierentiate into distinct cell types and
organs building the adult body. All these processes are driven by an intrinsic
blueprint of development written in the four-letter alphabet of the genomic
DNA sequence [260] and depend on the precise control of gene expression at
the level of transcription [206]. Multiple cells in an organism must develop
in a coordinated fashion. For this, multiple genes must be activated at the
same time in response to the same stimulus [291]. Interaction and commu-
nication of cells through signals and signal transduction pathways, which in
turn induces a particular combination of TFs, is crucial for accurate pat-
tern formation [306]. The precise patterns of gene expression are crucial for
development which are controlled by transcription factors binding to cis-
regulatory modules [310]. Thereby, TFs determine the rate of transcription
and mediate the accurate activation or repression of a particular gene in a
time- and tissue-specic manner, e.g. in the appropriate cell types or regions
of the developing organism [12].
The importance of TFs in development and dierentiation has been
demonstrated in a number of cases [306] as they initiate specic develop-
mental programs [306]. One example are the hox genes, which are involved
in the correct formation of specic body segments and the anterior-posterior
patterning of most metazoans [124, 148]. These genes are generally located
within tightly regulated clusters and their complex expression patterns
during development are regulated by local and long-range cis-regulatory
DNA elements. The expression of Hoxb1 in the mouse hind brain is the best
characterized example of a vertebrate Hox enhancer [82]. Other examples
include Pax6, which controls eye development [18] and MyoD, which is cru-
cial for muscle formation [210]. Recently, a specic combination of TFs has
been shown to be sucient to reprogram dierentiated cells into pluripotent
embryonic stem cells by a specic combination of TFs [135, 165, 269].
A specic spatio-temporal output of expression is achieved by integrating
the input of multiple transcription factors in CRMs [14]. Numerous cis-
regulatory elements direct the expression of a particular gene, each in a
dierent pattern [199].
A detailed knowledge of the location of all developmental CRMs, a com-
prehensive map of their combinatorial and temporal binding proles and the
ability to predict their spatio-temporal activity is necessary to understand
global cis-regulatory networks [310]. A central role in the regulation of de-
velopmental transcription has been attributed to DNA enhancer elements
and transcription factors binding to these regions [206]. Although the role of
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distant acting regulatory sequences directing spatial and temporal expression
patterns has been established in development, the identication of these se-
quences is still limited [261]. To predict spatio-temporal activity of enhancers,
a number of sequence-based models has been applied [249, 311]. However,
these methods are only accurate when tailored to individual CRMs [311]
or small numbers of regulatory modules [249]. Besides this, genome-wide
ChIP studies revealed extensive patterns of TF occupancy in a number of
developmental contexts in dierent organisms, including Drosophila [310],
mouse [154], and sh [195]. However, a static map of TF binding does not
reect the dynamic nature of gene expression and dynamic properties of
cis-regulatory networks are crucial to understand temporal expression pat-
terns [295]. A number of computational methods attempted to infer temporal
regulation of gene expression mainly by testing enrichment of TF motifs in
dierentially expressed groups of genes [67, 92, 296]. Zinzen and cowork-
ers [310] constructed a high-resolution atlas of cis-regulatory modules per-
forming ChIP-chip experiments for ve transcription factors at consecutive
time-points describing their temporal and combinatorial occupancy during
Drosophila mesoderm development [310]. As many biological processes are
spatially and temporally controlled at the level of transcription, understand-
ing the mechanisms of transcriptional regulation of gene expression will help
to understand the molecular mechanisms of dierentiation and development.
Alterations in cis-regulatory sequences responsible for proper transcrip-
tion are essential for morphological diversication and evolution of develop-
mental mechanisms [270]. As many developmental enhancers have a more
exible arrangement of binding sites than enhanceosomes, they are described
more accurately by the billboard enhancer model. The exact composition of
billboard enhancers are subject to rapid change in evolution, keeping the
overall output constant [172]. The position of individual binding sites within
CRMs involved in embryonic patterning is highly exible [202]. Enhancers
directing similar expression patterns can have dierent binding site arrange-
ments [203]. Whereas regulation of terminal dierentiation seems to be very
simple, regulatory sequences for early patterning can be quite long and con-
tain various dierent binding sites [202]. This can be explained by the fact
that in early patterning events, multiple binding sites are necessary for sens-
ing small dierences in the concentrations and combinations of regulatory
factors. However, only after cells express the relevant TFs, terminal dier-
entiation can occur [202].
Although many genes involved in specic developmental processes have
been identied, genes encoding transcription factors and cell signaling compo-
nents need to be further characterized to elucidated extensive gene regulatory
networks [163]. Regulation of development has been extensively analyzed in
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the sea urchin embryo [68, 209], frog [144], worm [131], and Drosophila [310].
However, little work has been done in mammals with few exceptions [253].
The comparison of sequences between dierent organisms has led to the iden-
tication of many thousands of conserved non-coding elements (CNEs) also
between distantly related species (such as human and puer sh) [166]. Ex-
perimental testing of randomly selected CNEs in mice [216, 286] and ze-
bra sh [251, 298] has identied CNEs as potential enhancers and many
CNEs show spatial- or temporal-specic enhancer activity [166]. One exam-
ple is the identication of vertebrate brain region-specic enhancers through
a high throughput analysis of expression-pattern associated CNEs in zebra
sh [166]. Highly conserved non-coding sequences have also been shown to
be associated with vertebrate development when comparing orthologous se-
quences between human and puer sh [298]. Most of the identied sequences
are located upstream of genes involved in developmental regulation [298]
and a number of these sequences have been shown to have some function
in vivo (e.g. [201]). In addition, ultraconserved elements (perfectly conserved
regions of at least 200 bp) between human, mouse, and rat [25] as well as
between human, mouse, and puer sh [242] have also been shown to be lo-
cated nearby genes encoding key regulators of development and transcription
[25, 34, 298]. Furthermore, these ultraconserved elements have been shown
to serve as long-range enhancers during mouse development [216]. There-
fore, extreme evolutionary non-coding conservation can serve as a powerful
predictor for mammalian tissue-specic enhancers [216].
Most developmental enhancers (irrespective of the size of the genome) are
typically between 200 bp to 1 kb in length [162] and contain multiple bind-
ing sites for dierent classes of sequence-specic TFs [12]. Additionally, these
enhancers often contain binding sites for repressors that inhibit expression
in inappropriate tissues [188]. The combination of computational and ex-
perimental approaches has greatly improved the collection of developmental
enhancers and has allowed investigating the exact arrangements of binding
sites of developmental enhancers [162].
Although the textbook view of developmental transcription is that regula-
tion is mediated by TFs and enhancer sequences, recent reports have also im-
plicated TFII complexes and core promoter elements in the precise regulation
of developmental transcription [206]. So far no universal eukaryotic promoter
elements have been identied, e.g. the TATA box occurs only in 10-20% of
eukaryotic genes [23, 205]. Furthermore, core promoter elements and TFIID
complexes can be highly diverse. Hence, it was suggested that core promoter
elements may be adapted to the transcription initiation machinery of spe-
cic cells [206]. In addition, enhancer elements were shown to interact with
dierent core promoters during distinct stages of development [206].
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1.5 Regulation of cholesterol biosynthesis
Cholesterol is central in human metabolism as cholesterol and its derivates,
steroids and bile acids, act as signal transducers and solubilizers of other
lipids [128]. In addition, cholesterol is a substantial component of cellular
membranes modulating the function of membrane proteins and it participates
in several membrane tracking and transmembrane signaling processes [128].
Dysfunction of cholesterol metabolism has been implicated in various diseases
such as cardiac diseases, dementia, diabetes, and cancer [127, 185].
Mammalian cells acquire cholesterol by de novo synthesis (see Figure 1.5)
in the endoplasmic reticulum (ER) and by endocytosis of lipoproteins [184].
Cholesterol esters in the core of lipoproteins (of which 70% are low-density
lipoproteins [22]) are hydrolyzed in late endosomes and lysosomes, and free
cholesterol is released into the cell [184]. Feedback control mechanism of
cholesterol is mediated by a cell surface receptor for a plasma cholesterol
transport protein called low density lipoprotein receptor (LDLR) [100].
These receptors bind LDL and carry it into the cell by receptor-mediated
endocytosis [43]. The internalized lipoprotein is delivered to lysosomes
where its cholesterol esters are hydrolyzed [43].
The sterol regulatory element binding proteins (SREBPs) are key reg-
ulators of cholesterol and fatty acid metabolism [120] by regulating mul-
tiple genes involved in cholesterol biosynthesis and uptake [44]. SREBPs
belong to a large class of TFs containing basic-helix-loop-helix-leucine zip-
per (bHLH-Zip) domains [240] and are synthesized as inactive precursors
bound to the membranes of the ER [44, 101]. A two-step proteolytic process
of cleavage is required in order to release their amino-terminal bHLH-Zip
containing domain into the nucleus. SREBPs bind like all bHLH proteins to
E-boxes (5'-CANNTG-3', with N representing any base) and a specic DNA
sequence, the sterol regulatory element (SRE) (5'-TCACNCCAC-3') [140].
SCAP (SREBP cleavage activating protein) is a required activator of SREBP
cleavage and the activity is abolished by sterols [44]. SCAP contains a
sterol-sensing domain regulating the transport of SREBP from the ER to
the Golgi [252]. In the Golgi the cleavage is initiated by a membrane-bound
serine protease termed Site-1 protease (S1P) that clips SREBP at site 1. This
cleavage breaks the covalent bond between the two transmembrane domains
of SREBP but both halves remain attached to the membrane. A second
membrane-bound zinc metalloproteinase termed Site-2 protease (S2P) clips
the rst transmembrane fragment at site 2, which releases the active domain
into the cytosol from where it enters the nucleus [44].
Three isoforms have been identied in mammals, SREBP1a, SREBP1c,
and SREBP2 [101] which are encoded by two dierent genes (SREBF-1
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Figure 1.5. Human cholesterol biosynthesis. Key intermediate metabo-
lites of the pathway are represented as circles. Arrows indicate the cholesterol
pathway. CoA: coenzyme A.
and SREBF-2) [44]. SREBP1a is involved in the regulation of cholesterol
and fatty acid biosynthesis, whereas SREBP1c and SREBP2 regulate fatty
acid metabolism and cholesterol biosynthesis, respectively [120]. SREBPs
are weak transcriptional regulators themselves and act in combination with
other transcription factors, i.e. Sp1 transcription factor (SP1) and nuclear
transcription factor-Y (NF-Y) [72, 134, 234, 241]. Although many SREBP-
responsive genes involved in the uptake and synthesis of cholesterol and
fatty acids have been described [22, 121, 231], it is suggested that only a
smaller fraction of SREBP target genes have been discovered so far [121].
Furthermore, little is known about interactions and simultaneous binding of
SREBP with other transcription factors [231]. Diseases caused by dysfunc-
tional cholesterol uptake and synthesis like Familial Hypercholesterolemia
and Niemann-Pick Disease Type C are not fully understood and open ques-
tions remain concerning the regulation of cholesterol metabolism and molec-
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ular interactions of known cholesterol-regulating factors [22].
1.6 Machine learning
Machine learning emerged from the subeld of computer science known as
articial intelligence (AI). Machine learning systems \learn" from previous
experience. Accumulated experience (e.g. through experimental data) allows
a machine to develop new knowledge which leads to a better performance on
a specic task over time. Learning from experience is the central idea to
the dierent types of problems encountered in machine learning, especially
problems involved in classication. The general goal of all problems is the
identication of a systematic way of classifying a new example. Classication
is based on knowledge obtained from learning (or training) samples together
with measurements obtained from a similar new example. The number of
classes needs to be nite and known and the class of each example needs to
be determined and known. [133]
Machine learning can be divided into supervised learning and unsupervised
learning.
Unsupervised learning The goal of unsupervised learning is the explo-
ration of characteristics of the input variable when there is no appropriate
information about an output variable available. This approach was not fol-
lowed in this thesis.
Supervised learning The goal of supervised learning is to nd a function
of the input variables to approximate the known output variables. For
this, the learning algorithm receives a set of continuous or categorical input
variables and a correct output variable. This way, the relationships between
the input variables and the output variable can be analyzed. If the output
variable is continuous a regression problem is faced, whereas a categorical
output variable faces a classication problem.
The concept of generalization aims at making good predictions when
applied to a data set that is independent of the data used to t the model.
Not using an independent data set will result in overestimating the model's
predictive accuracy. One way of creating an independent data set is to
hold back a proportion of the data set from the model tting and use it for
prediction. Usually, the data set is separated into three non-overlapping and
independent data sets. [133]
1.6. MACHINE LEARNING 27
Training set The training set is used for the assessment of the data, pre-
liminary testing, looking for patterns, trying dierent models, and eliminat-
ing outliers.
Validation set The validation set is used to assess the dierent models
and to select the best model possible.
Test set The test set is used to assess the performance of the specied
nal model.
To assess the performance of a particular model, the prediction error
can be used as a measure of prediction accuracy. In classication, a classier
is built from the training set and used to predict the classes of the test set.
The proportion of all misclassied samples in the test set is then dened as
the prediction error. Other methods to assess the test error are based on
cross-validation [264] and bootstraping [74] and are used when limited data
samples are available.
V -fold cross-validation During cross-validation, the entire data set is
divided randomly into equally sized V non-overlapping groups with V be-
ing any number between 2 and the overall sample size. One group is then
successfully removed from the entire set and the other V -1 groups are used
as the training set to t the model. The omitted group serves as the test set
and its output variable is predicted using the tted model to determine the
prediction error of the omitted group. This procedure is repeated V times,
each time removing a dierent group. The overall test error is estimated by
averaging over the obtained V prediction errors. This way, the entire data
set is used in a more ecient manner than the mere division into a training
and an independent test set.
Bootstrapping A bootstrap sample is randomly drawn from the entire set
with replacement. Using this sample, a model is tted and the prediction
error assessed with the remaining data. This procedure is repeated at least
1000 times, each time assessing the prediction error. The test error is then
estimated by averaging all the prediction errors.
When learning a model one has to be careful not to overt the model.
Overtting occurs when the model is too large or complicated, or when the
data set contains too many parameters relative to the size of the training
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set. It usually estimates well the training set but results in a large prediction
error on the test set. [133]
1.6.1 Decision trees
Decision tree learning is one of the most extensively used methods for in-
ductive inference. Tree-based methods have been used in a variety of elds
such as biomedical and genetic research, marketing, political science, speech
recognition, and other applied sciences. Decision trees are intuitive and easy
to interpret as the sequences of decisions made to assign a class label to an
input is easy to follow [145]. Furthermore, they can be easily extended to cat-
egorical rather than numerical variables. Furthermore, decision tree learning
methods are robust to errors and can cope with missing values [193]. How-
ever, a challenge in decision trees remains the induction of decision tress of
small size and depth [145].
Examples are classied by sorting them down the decision tree from the
root to some leaf node. At each node a test of some variable is specied
and the example is moved down the branch from that node corresponding
to the value of the variable in the given example. An example for a decision
tree is given in Figure 1.6. Decision trees are best suited to problems where
instances are represented by a xed set of variables and their values with a
discrete output variable [193].
A simple and powerful method to infer classication rules from a set of
labeled examples is the top-down induction of decision trees [223]. One of the
earlier approaches are Friedman and Breiman's work resulting in the CART
system [40, 88] and the ID3 algorithm [223] with its successor C4.5 [225].
The central idea of the nonparametric statistical method of classication
and regression trees (CART) [40] is an algorithm known as recursive parti-
tioning. This involves a step-by-step procedure to construct a decision tree
by either splitting or non splitting each node in the tree into two daughter
nodes. The CART algorithm (or the related C4.5 methodology) asks a se-
quence of boolean questions and the results are therefore relatively easy to
understand and to interpret. In the CART methodology, the input space is
partitioned into a number of non-overlapping rectangular or cuboid regions.
Each region is viewed homogeneous to predict the output. Classes are as-
signed to the regions with sides parallel to the input space. This kind of
partition corresponds to a classication tree. Similar to classication trees,
regression trees are constructed by recursive-partitioning, generally referred
to as recursive-partitioning regression. [133]
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Weather
Sunny Rainy
Wind
Yes No
Go for a run Play tennis
Temperature
Warm Cold
Stay insideTake an umbrella 
and go for a walk
Figure 1.6. A decision tree for the concept of Saturday afternoon
activity . An example is classied by passing it down the tree to the appro-
priate leaf note. This tree classies Saturday afternoon according to what
activity is suitable for the given weather, e.g. if it is rainy and cold outside
the appropriate activity is staying inside.
Classication Trees
A classication tree is the outcome of asking an ordered sequence of questions
that terminates with the prediction of a class. Each question depends on the
answer to the previous question in the process.
At each node in the tree a decision rule is implemented splitting the ex-
amples into two or more partitions. The starting point of a classication tree
at the top of the tree is called the root node. It consists of the entire training
set that is successively passed down the tree. A terminal or nonterminal
node consists of a subset of the set of variables. A nonterminal node is also
called a parent node and a binary split divides the node into two daughter
nodes. The binary split is determined by a Boolean condition on the value of
a single variable. The observed value of a variable can either satisfy (\yes")
or not satisfy (\no") the condition at that split. Observations satisfying the
condition for the variable at a particular node are passed down to one of
the daughter nodes, all other observations not satisfying the condition drop
down to the other daughter node. A terminal node or leaf node does not
split and is assigned a class label depending on the class of the majority of
the observations at that node (called the plurality rule). Each observation
is passed down the tree until it falls into one of the terminal nodes where
it is assigned a class label. The set of all terminal nodes of a tree is called
a partition of the data. If a tree has only a single split with two terminal
nodes, it is called a stump.
To grow a classication tree, one has to determine how to choose the
Boolean conditions for splitting at each node, which criterion should be used
to split a parent node into its daughter nodes, how to determine a node to
be terminal, and how to assign a class to a terminal node. [133]
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Tree growing procedure
The tree growing algorithm needs to decide at each node which variable is
split \best". All variables present at the node need to be considered for the
split and each one needs to be evaluated to determine the best variable for the
split. However, for each given variable the best split needs to be determined
rst. To determine the best possible split, a measure for the goodness of
a split is needed which is dened by the node impurity function. The two
most commonly used impurity functions are the entropy function [223] and
the Gini diversity index [40]. The entropy function is dened as
i() =  
KX
k=1
p(kj)log(p(kj)) (1.4)
where p(kj) is the probability that an observation is correctly classied as
class k at node . The Gini diverstiy index is dened as
i() = 1 
X
k
p(kj)2 (1.5)
where p(kj) is also the probability that an observation is correctly classied
as class k at node . The Gini index is often the default function in tree
growing software as it is frequently the best splitting rule. It focuses on
separating one class at a time from the remaining data and thereby tries to
produce pure nodes, whereas entropy aims at equalizing sample sizes in the
generated subsets at each split [38]. The reduction in impurity gained by
splitting the parent node into its daughter nodes gives the goodness-of-split
at a particular node.
The sequential splitting process of growing a tree is called recursive
partitioning. Each tree growing procedure starts with the root node, which
consists of the entire training set. The tree algorithm determines the best
split at the root node for each variable using the chosen \goodness-of-split"
criterion. The split with the largest value over the best splits of all single
variables is chosen as the best split at the root node. According to the deter-
mined split, the root node is split into two daughter nodes. Each daughter
node is then split in the same way as the root node and the subsequent
nodes are split accordingly. This results in a greedy search for an acceptable
decision tree where earlier choices are never reconsidered [193]. In a binary
tree every node has exactly two daughter nodes. A tree is saturated if the
procedure is conducted until none of the nodes can be split any further. A
terminal node can also be determined based on a dened stopping criteria.
To restrict the growth of a tree, a node can be declared terminal if it is smaller
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than a predened threshold. The growing procedure can also be restricted
by setting a minimal value for the improvement of the goodness-of-split value
at a node. However, it is usually better to grow a saturated tree and then
\prune" it back [40]. The idea of pruning is to let the tree grow \large" and
then successively remove branches with little statistical validity [91, 191, 224]
until the tree has obtained the \right size" using a bottom up approach [40].
Therefore, a pruned tree is a subtree of the original saturated tree.
A good estimate of the misclassication rate can be computed by using an
independent test set or cross-validation to determine the best subtree. [133]
1.6.2 Ensemble learning
How to lower the generalization error of a learning algorithm by reducing the
bias or the variance is one of the most important research topics in machine
learning. This is related to the idea of \instability" of a prediction or classi-
cation method. A classication is unstable if small perturbations of the train-
ing set lead to major changes in the resulting classier. Due to overtting,
unstable classiers have high variance and low bias. In contrast, undertting
leads to a high bias. By this denition, decision trees are unstable. However,
instability of a classier can be used to improve the accuracy of the learn-
ing algorithm. By perturbing the training set, an ensemble of dierent base
classiers is generated. Using these combined classiers is called ensemble
learning or committee-based learning and their success often depends on the
degree of instability of the base classier. Ensemble learning algorithms gen-
erate many classiers and aggregate their results [167]. Growing an ensemble
of trees and determining the most popular class has signicantly improved
classication accuracy [39]. Two methods for ensemble learning are bagging
[37] and boosting [86] which dier in the way perturbations are generated.
Whereas bagging was designed to reduce variance, boosting appears to rather
reduce bias. Another example for ensemble learning is random forest [39].
Bagging
Bagging is an acronym for \bootstrap aggregating" [37]. Perturbations of
the training set are generated by random and independent drawings from
the training set. It was the rst procedure successfully combining an en-
semble of learning algorithms that improved the performance over a single
learning algorithm. Bagging starts by drawing B bootstrap samples from
the training set where each bootstrap sample is gained by repeating sam-
pling with replacement from the training set. For each bootstrap sample a
classication tree is grown independently of earlier trees and each sample
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is dropped down each of the bootstrap trees. The class of each sample is
determined by class which was predicted by the majority of trees. This clas-
sication procedure is called the majority-vote rule. Those observations not
included in the bootstrap sample are called out-of-bag (OOB) observations.
These OOB observations serve as an independent test set. The OOB mis-
classication rate is then determined by the proportion of classes where the
predicted class diers from the actual class for all observations in the training
set. [133]
Boosting
In contrast to bagging, boosting [86] is an iterative process where each clas-
sier is dependent on the performance of those built before [297]. Thereby,
the performance on previously misclassied samples is improved. Whereas
in bagging all single classiers are equally weighted, boosting weights clas-
siers according to their contribution in performance. In terms of decision
trees, successive trees give extra weights to incorrect predictions by earlier
trees [167]. Boosting aims at enhancing the accuracy of samples that are dif-
cult to predict using a \weak" binary classication learning algorithm. A
\weak" classier is only marginally better than random guessing and classi-
es correctly barely more than 50% of the time. The term \boosting" derives
from the idea of creating a \strong" classier by improving (\boosting") the
performance of a single classier. This improvement is achieved by combining
classication votes from an ensemble of similar \weak" classiers. [133]
Random forest
Random forest is one of the most eective ensemble methods available and is
an extension of the idea of bagging [39]. Whereas in bagging randomization
is only used in choosing the data set to grow the tree on, in random forest
randomization is also a crucial part of constructing each tree, thereby adding
another layer of randomization to bagging. Random forest follows the bag-
ging procedure by drawing n bootstrap samples from the original data set.
However, these approaches dier in the way the trees are grown from the
bootstrap samples. An unpruned classication tree is grown for each boot-
strap sample. Whereas in single decision trees each node is split according
to the best split among all variables, in random forest the best split at each
node is determined among a randomly chosen subset of all variables. Bag-
ging constitutes a special case of random forest when all variables are used at
each node instead of a subset. New data is then predicted by a majority vote
of all trees in the forest. The error is estimated using the OOB observations
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of each bootstrap sample. Using the additional layer of randomization, the
correlation between the dierent tree-structured classiers is reduced.
Random forest is easy to use as there are only two tuning parameters,
the number of bootstrap samples and the number of variables randomly cho-
sen as a subset at each node. In addition, random forest cannot overt as
the generalization error converges to a limit when the number of trees in
the forest is increased. Furthermore, random forest can be used to evaluate
the variables in a data set and assess the importance of each variable. This
is achieved by classifying the OOB observations and compute the OOB er-
ror rate. The OOB values for the specic variable are then permuted while
all other variables remain unchanged and the altered OOB observations are
re-classied. If a variable is important, the altered data leads to a poorer
classication. The dierence between the two computed error rates averaged
over all trees in the forest serves as a measure for the importance of that
variable. To identify structure in the data or for unsupervised learning, a
proximity measure can be estimated. Proximity between two instances is
given as the number of trees where both instances fall in the same termi-
nal node under the assumption that \similar" observations fall in the same
terminal node more often than dissimilar ones. [133]
1.7 Network analysis
To understand cellular processes, it is necessary to analyze cellular molecules
in the framework of pathways and networks. Experimental studies and large-
scale screens have provided interaction data that can be assembled into a
network format. The network can then be analyzed for signicant biological
properties through its topological structure [308]. The relationships between
the dierent biological entities, e.g. interactions between proteins, can be
described with the language of graph theory which oers a mathematical
abstraction [122]. A graph consists of a set of nodes and a set of edges.
The edges connect the nodes, representing the relationship between them.
For example, nodes could represent dierent proteins and the edges physi-
cal interactions between the proteins. Examples of biological graphs include
regulatory networks, signal transduction networks, protein-protein interac-
tion networks, and metabolic networks. Depending on the characteristics of
the biological data, networks can be directed or undirected [308]. In case of
transcriptional regulatory networks, edges within a graph can be directed to
represent the direction of regulation [122].
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Metabolic networks One well-established type of biological networks
are metabolic networks. It can be easily constructed when key bio-
chemical relationships between key metabolic genes are known. It repre-
sents biochemical reactions between the dierent substrates facilitated by
metabolic enzymes and can represent certain pathways such as cholesterol
biosynthesis (see section 1.5).
Signaling networks Extracellular signals are connected to the control of
transcription factors via signal transduction pathways. These networks de-
scribe the interactions between signaling molecules within the cell from the
extracellular input to the specic transcription factors involved in the distinct
process.
Regulatory networks Large-scale identication of transcription factor
binding sites by ChIP-chip or ChIP-Seq has allowed the construction of
transcriptional regulatory networks, e.g. [292]. These networks represent the
regulation between transcription factors and their respective genes.
Protein-protein interaction networks Interactions between proteins
can be assembled into a protein-protein interaction (PPI) network. These
networks represent the largest and most diverse biological data sets available
to date [308]. Tightly connected proteins are often involved in similar
processes. Functional annotations of interacting proteins may indicate
potential roles for unannotated genes and improve our understanding of true
pathological mechanism of a disease [308]. PPI network models are often
used as a simplication of more elaborated signaling networks [246].
1.7.1 Graph theory
A graph G = (V;E) is specied by its set of nodes V and its set of edges
E. Each element of E consists of a pair u; v of elements of V and edges can
be assigned weights, directions, and types. Two nodes are adjacent to each
other if they are connected by an edge. Likewise, two edges are adjacent if
they are joined by a node. If all nodes in a graph are connected with an
edge, the graph is called a complete graph. [122]
A graph can be represented by its adjacency matrix which is a square
matrix A whose rows and columns correspond to nodes. Its elements Aij
denote the presence of an edge from node i to node j and possibly the weight
of the edge. The adjacency matrix is symmetric for undirected graphs. [122]
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The rst step in understanding network architecture and performance is
the analysis of its network topology. The most important and commonly
used topological features in cell biology include degree, clustering coecient,
shortest path length, and betweenness centrality [308].
The simplest measure to characterize the role of a node in a network is
the node degree or connectivity [6]. The degree or connectivity of a node
v is equal to the number of edges incident at node v. A node with many
connections has a higher node degree, which reects its importance in the
network [308]. The degree for directed networks can be divided into in-degree
and out-degree that represent the number of incoming and outgoing edges,
respectively. One example are transcriptional regulatory networks, where
the in-degree can represent the number of transcription factors regulating
a target genes whereas the out-degree reects the number of target genes
regulated by transcription factors [142]. Most target genes have only a small
number of transcriptional regulators, whereas just a small set of transcription
factors has a high number of connections [106].
The clustering coecient of a node measures the degree to which the
neighborhood of a node resembles a completely connected subgraph (clique).
It is dened as the ratio of the number of actual edges between the node's
neighbors to all possible edges between them. The clustering coecient is
given by
C(v) =
2E
kv(kv   1) (1.6)
where E is the number of edges connecting the immediate neighbors of node v
and kv is the degree of node v. The clustering coecient measures the
cliquishness, or transitivity, of the local neighborhood [6] and quanties the
probability of two nodes that are both neighbors of the same third node also
being connected to each other [98].
The shortest path length between two nodes represent the shortest
distance between the two nodes. The maximal length of the shortest path in
a network is called the graph diameter [308].
The betweenness centrality is dened as the fraction of shortest paths
between all pairs of nodes passing through a node or edge. The betweenness
centrality is given by
C(v) =
X
s 6=v 6=t2V
sst(v)
sst
(1.7)
where sst(v) denotes the number of shortest paths between node s to node
t and node v lying on a shortest path between s and t and sst denotes
the number of all shortest paths from s to t. Betweenness centrality is an
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estimator of the trac load through a node and the rate at which signals
pass along the edges [85, 200, 308].
There exist three distinct models of networks according to their topology,
random networks, scale-free networks, and hierarchical networks [20]. These
network models are distinguished by their distribution of node degree [142].
The connectivity distribution given by
P (k)  Nk
N
(1.8)
where Nk is the number of nodes with k neighbors. It oers a more detailed
insight into the structure of a graph. Erdos and Reny [78] showed that the
connectivity of simple random graphs follows a Poisson distribution. How-
ever, in many real networks the degree distribution P (k) follows a power-law
distribution
P (k)  k  (1.9)
where  is a constant depending on the network usually in the range of
2 <  < 3 [1, 19]. In these network, the majority of nodes only have a few
connections whereas only a small number of nodes are highly connected [6].
These networks are called scale-free. Nodes with many connections are also
called hubs which often play a crucial role in cellular networks [20, 136, 220].
Another common property of many networks is the community structure,
the division of nodes into highly connected groups in the network with only
sparse connections between them [200].
Figure 1.7. Random and scale-free networks. A A random network with
a Poisson connectivity distribution. B A scale-free network with a power-law
connectivity distribution where most nodes are scarcely connected and only
few nodes, called hubs, have many connections (shown in dark gray).
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The majority of cellular (e.g. metabolic networks, protein-protein-
interaction networks) as well as non-cellular networks (e.g. social world
networks, the World Wide Web) seem to approximate a scale free topol-
ogy [20]. In scale-free networks, the nodes usually are highly connected
such that each node can be reached from every other node in a minimal
number of steps (called the small world property) [64]. These networks have
therefore a small graph diameter [189] and a high clustering coecient [308].
The scale-free topology provides robustness to the network with increased
exibility to random perturbations where the loss of individual nodes usually
has no eect on the overall network topology. Nevertheless, it is susceptible
to targeted attacks at heavily connected critical hubs [2, 6] and mutations
aecting hubs are more likely to cause a defect [308].
Although the analysis of cellular networks has given details into the bi-
ological system of interest, they usually represent a static representation of
the biological system. However, the cell is far from a static environment and
new approaches are needed to incorporate the dynamic nature of biological
systems [6].

Chapter 2
Methods
2.1 Identication of spatio-temporal specic
regulatory modules
The complete workow of the analysis is shown in Figure 2.1.
2.1.1 Identication of transcription factor binding
sites
Sequences from 10,000 base pairs (bp) upstream to 100 bp downstream of the
transcription start site (TSS) for 32,290 human genes (Build 36.3) as well as
for 33,063 genes for mouse (Build 37.1) and 27,110 genes for rat (Build 4.1)
were retrieved from the National Center for Biotechnology Information
(NCBI, ftp://ftp.ncbi.nlm.nih.gov/). Transcription factor (TF) anno-
tations and associated position weight matrices (PWMs) were obtained from
TRANSFAC (Release 12.1) [183] yielding 549 human transcription factors
(455 PWMs), 407 transcription factors (TFs) for mouse (410 PWMs), and
366 TFs for rat (471 PWMs). Each PWM binding site was mapped to the
corresponding binding site of its associated TFs. TFs sharing the same
PWM were grouped together. The grouping resulted in 152 TF-groups
for human (see Table A.1), 139 for mouse, and 141 TF-groups for rat
which were used for further analysis. The detection of TF binding sites
based on the respective PWMs was performed with the software package R
(www.r-project.org) as described previously [227, 294]. Predicted binding
sites with a p-value above P = 0.05 were discarded.
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Figure 2.1. Workow for the identication of tissue- and temporal-
specic regulatory modules in development and dierentiation.
A Motifs (position weight matrices) for transcription factor binding sites were
collected from a database. B Upstream sequences were gathered for each tran-
script. Promoters (+/- 100 base pairs of the transcription start site, TSS) and
enhancers (dened by accumulation of binding motifs and phylogenetic conser-
vation, 2,000-10,000 base pairs upstream of the TSS) were selected. C Statisti-
cal and combinatorial analysis of transcription factor binding sites of promot-
ers and enhancers. D Characterization of single motifs with respect to their
distributions in the observed sequences (0-10,000 bases upstream of the TSS).
E Assembly of regulatory modules. A regulatory module consisted of a pair of
transcription factors binding at the promoter region and a pair of transcrip-
tion factors binding at the enhancer region. F Network analysis. G Gene
expression data was taken from microarray studies of the development of sev-
eral mouse tissues and of the dierentiation of human stem cells. H A time
series analysis was performed to identify genes being dierentially expressed
at distinct (developmental) time intervals and tissues/cell types. I The regu-
latory modules were used to predict dierential expression of developmental
time intervals.
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2.1.2 Identication of combinations of transcription
factors
Predicted TF binding sites were combined into pairs of TFs. Regions 100
base pairs (bp) upstream and downstream of the transcription start site
(TSS) were used as promoters, and regions starting 2,000 bp and ending
10,000 bp upstream of the TSS were used as potential enhancer regions.
Combinations of TFs for promoters were obtained by pairing non-overlapping
TF binding sites co-occurring in the promoter region of a gene using a sliding
window of 20 bp. Only pairs occurring in at least 10 genes were taken into
further consideration. To decrease false positives of predicted transcription
factor binding sites, only conserved binding sites were analyzed in enhancer
regions. To determine the conservation of human, mouse and rat binding
sites, we analyzed pair-wise alignments between human and chimp, mouse
and rat, and rat and mouse, respectively. Chained and netted pair-wise align-
ments of human (UCSC version hg18) and chimp (UCSC version panTro2),
of mouse (UCSC version mm9) and rat (UCSC version rn4), and of rat
(UCSC version rn4) and mouse (UCSC version mm9) were downloaded from
UCSC [235] in the axtNet format (ftp://hgdownload.cse.ucsc.edu/).
Conserved regions between human and chimp, mouse and rat, and rat and
mouse were determined by the given aligned regions in the alignment les.
Predicted binding sites were compared to the identied conserved regions
and taken if binding sites occurred in these conserved regions. Pairs of
non-overlapping co-occurring transcription factors in enhancer regions were
determined using a sliding window of 20 bp (same size as for promoter
regions). To analyze enhancer regions with a comparable size to promoter
regions, we regarded sequences of a 200 bp sliding window. As enhancer
were shown to consist of clusters of TFs [13, 158], only regions in which at
least 10 binding sites occurred were considered as enhancer regions and TF
pairs occurring in at least 10 genes were considered further.
2.1.3 Identication of regulatory modules
Regulatory modules were constructed by combining two TF pairs occurring
at the respective promoter and enhancer regions of a gene. Regulatory mod-
ules occurring in at least 10 genes were taken for further analysis. Hence,
regulatory modules consisted of a combination of a pair of co-occurring tran-
scription factors at the promoter and the enhancer region. To show that
combinations of TF pairs of enhancers and promoters show better specicity
than combining only TF pairs binding at the promoter, we also constructed
the latter combinations. For this, two pairs of co-occurring transcription
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factors in the promoter region were combined for each gene and taken for
further analyses if the regulatory module occurred in at least 10 genes.
2.1.4 Gene expression analyses of mouse embryonic
development and human stem cell dierentiation
Gene expression data of mouse embryonic development and dieren-
tiation of human stem cells were retrieved from the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/). For mouse embryonic
development, gene expression data was analyzed comprising early cardiac
development (GSE1479), the developing prefrontal cortex (GSE4675), fa-
cial prominences (GSE7759), early development of the brain (GSE8091),
development of the liver (GSE13149), ovary development (GSE5334), and
development of testis (GSE4818). Quality was assessed by manual inspec-
tion of probe intensity distributions of each array and discarded if the
MA-plots showed abnormal distributions. Figure 2.2A shows an MA-plot
of a good quality array with an expected distribution where most genes
show no dierential expression. In contrast, Figure 2.2B demonstrated
an MA-plot of a bad quality array with a skewed distribution that was
discarded from the analysis. This quality control was also applied in
Schramm and coworkers [247]. We discarded three samples from the dataset
of early brain development, four samples from ovary development and one
sample from testis development. For dierentiation of human stem cells,
we analyzed gene expression data of cardiomyocytes (GSE13834), chon-
drogenic dierentiation (GSE10315), myoblast dierentiation (GSE3780),
myelopoiesis (GSE12837), and neural dierentiation (GSE9940). Similar to
the data sets for mouse, we discarded data with low quality. We discarded
one sample from the cadiomyocytes, four samples from dierentiation of
chondrogenesis, 24 samples from dierentiation of myoblasts, 11 samples
from myelopoiesis and four samples from neural dierentiation. The data
was analyzed using the aymetrix package [94] of R (www.r-project.org)
and normalized with VSN normalization [123]. For better comparability, for
each gene expression study, time points were grouped into three time inter-
vals: early, mid, and late expression, e.g. in the human myelopoiesis data set
(GSE12837), the haematopoietic stem/progenitor cells (HSC) were grouped
at the early time interval, myeloid precursors at the mid time interval and
terminally dierentiated cells at the late time interval. Each dataset was
tested for dierentially expressed genes between the dierent time intervals
using the Rank Product Test [41]. Signicant genes were determined using
a cuto for false positives smaller than 5% (false discovery rate < 0.05).
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Figure 2.2. MA-plots for quality control. A MA-plot of a good quality
array with an expected distribution. B MA-plot of a bad quality array with
a skewed distribution.
2.1.5 Estimating tissue and time specicity for TFs,
combinations of TFs and regulatory modules
For each TF we determined genes with binding sites for the TF identied by
our PWM-scans and regarded them as potentially regulated by the specic
TF. Using Fisher's Exact tests, we tested if these regulated genes were sig-
nicantly enriched in the list of dierentially expressed genes of each time
interval for each gene expression study (tissue). We dened this TF to be
tissue-specic if such an enrichment occurred only for one tissue (number
of tissues = one), otherwise we specied this TF to regulate two or more
tissues (number of tissues > 1). Similarly, we dened the TF to be time
interval-specic if we determined an enrichment of its regulated genes in the
list of dierentially expressed genes of a tissue at one time interval (number
of time intervals = one), and more than one time interval otherwise (number
of time intervals > 1). This enrichment analysis was conducted for all TFs.
The results were summarized for all TFs and the percentage of TFs per time
interval and tissue identied, yielding the results shown in Figure 3.1A and
Figure 3.3A. The same procedure was carried out for pairs of TFs at promot-
ers (Figure 3.1B and Figure 3.3B), pairs of TFs at enhancers (Figure 3.1C
and Figure 3.3C), and regulatory modules (Figure 3.1D and Figure 3.3D).
To assess the signifcance of temporal specicity of regulatory modules com-
pared to pairs of TFs at promoters, a Fisher's Exact test was conducted to
test if the number of regulatory modules specic for a single time interval
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was enriched compared to the number of TF pairs at promoters specic at a
single time interval.
2.1.6 Prediction of time intervals using regulatory
modules
To identify relevant regulatory modules for temporal regulation of gene ex-
pression during development and dierentiation and to estimate their po-
tential power to regulate distinct gene groups for the progression of devel-
opment, we employed the method of random forest as a machine learning
method (classier). We set up a classication task for two classes. For this,
we identied all genes that were dierentially expressed at only one time
interval. As little data was available for the mid time interval (n = 7) and
to simplify classication, we used only two time intervals (early and late).
The early time interval constituted the rst class and the late time in-
terval the second class. The classiers were trained to predict the cor-
rect time interval for each gene, using the information which specic reg-
ulatory modules were regulating the respective gene (regulatory modules
served as features for the classier). We trained 10,000 decision trees yield-
ing an ensemble classier (random forest) using the package randomFor-
est [167] (http://cran.r-project.org/web/packages/randomForest) in
R (www.r-project.org) with 80 variables randomly selected at each node
(parameter mtry), a maximum node size of 2 (parameter maxnodes), and
enabling the assessment of variable importance (parameter importance). To
identify regulatory modules with the best discriminative behavior, we applied
the Gini criterion which minimizes the impurity of the children nodes at each
split in the tree. To focus on the best descriptors, we used the top 5% of the
features for classication. A 10 times 10-fold cross-validation was applied to
determine the performance of the classier (yielding accuracy, sensitivity and
specicity for the classier). For comparison, we also trained a random for-
est using pairs of co-occurring transcription factors at promoters as features
with the same parameters as for regulatory modules. Similar to regulatory
modules, the most important pairs of transcription factors at promoters were
identied according to the Gini criterion. The top 5% of the features were
used for predictions and the performance of the classier was determined
employing a 10 times 10-fold cross-validation.
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2.1.7 Denition of TFs with TSS-enriched, TSS-
depleted and uniformly distributed binding sites
For each transcription factor, the distribution of binding sites was de-
termined with respect to the annotated transcription start site (TSS)
for all genes. Transcription factors were grouped into three categories:
transcription factors with binding sites predominantly around the TSS
(TSS-enriched-BS), transcription factors with a depletion of binding sites
at the TSS (TSS-depleted-BS), and transcription factors showing a uniform
distribution of binding sites (uniformly-distributed-BS). For this grouping,
a Wilcoxon signed-rank test was conducted for each transcription factor to
test if the distribution of binding sites at the TSS (+/- 100 bp around TSS)
follows the distribution of the remaining binding sites. To correct for multi-
ple testing, a Benjamini-Hochberg correction [26] was applied. Transcription
factors with P < 0.05 and a dierence of the medians of the distributions of
at least four bp were classied as transcription factors preferentially binding
at the TSS (TSS-enriched-BS) or as transcription factors with binding sites
depleted around the TSS (TSS-depleted-BS) depending on the sign of the
dierence of the medians of the distributions. All other transcription factors
were termed transcription factors with a uniform distribution of binding
sites (uniformly-distributed-BS).
To further distinguish TFs with TSS-enriched-BS from TFs with
TSS-depleted-BS, we determined the ratio (log-ratio) of the number of
binding sites at promoters and enhancers per transcription factor. Binding
sites at the promoter region and the enhancer region were counted per
transcription factor for all genes. The number of binding sites was then
normalized according to the width of the binding region (200 bp for the pro-
moter region and 8,000 bp for the enhancer region). The log ratio of binding
sites at promoters and enhancers was determined and compared between
transcription factors preferentially binding at the TSS (TSS-enriched-BS)
and transcription factors with a depletion of binding sites close to the TSS
(TSS-depleted-BS). The dierence of the log ratios between the two classes
of TFs was determined using a Wilcoxon test.
2.1.8 Constructing the networks
Using the identied co-occurring transcription factor pairs as links (see sec-
tion 2.1.2), two networks were constructed, one for promoters and one for en-
hancers. To assess if pairs of TFs of the same group (TSS-enriched-BS, TSS-
depleted-BS, uniformly-distributed-BS) occurred more often than expected
by chance, we performed a permutation test with 10,000 permutations of the
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class labels. Connectivity and betweenness centrality were determined for
each node in the network and their maxima were identied for both networks
for transcription factors of the categories TSS-enriched-BS and TSS-depleted-
BS. In addition, a protein-protein-interaction network of TFs was constructed
using physical binding information from a public repository (BIND [16]) and
each transcription factor was associated to its corresponding protein in the
network. This network was analyzed for the same properties as the described
promoter and enhancer networks.
2.2 Identication of novel putative SREBP
target genes
The complete workow is shown in Figure 2.3. Whereas I conducted all bioin-
formatics analyses, all experimental procedures were carried out by Jessica
Schilde and Heiko Runz at the Institute of Human Genetics of the Univer-
sity Hospital Heidelberg in the group of Heiko Runz \Regulation of cellular
cholesterol metabolism".
2.2.1 Gene expression analysis of HeLa cells and pa-
tient broblast cell lines
Gene expression data of HeLa cells were taken from Bartz and Kern and
co-workers [22] and were downloaded from the public microarray database
ArrayExpress (Acc.No. E-TABM-599). The raw data was normalized with
VSN normalization [123]. Of the original cDNA probe set, 40,847 cDNA-
clones (Unigene Build 215) were mapped to 17,848 human genes (NCBI
Build 36.3) for further analysis. Median values were taken if a gene was
represented by multiple probes on the array. The broblasts were cultivated
under similar cell culture conditions as the HeLa cells as described in [22]
and mRNA of three biological replicates each was hybridized against Illu-
mina Human Sentrix-8 chips. Labeling, hybridization and scanning of the
Illumina chips was performed in the Genomics and Proteomics Core Facil-
ity of the German Cancer Research Center according to Illumina's recom-
mended protocols. The raw data of the broblasts was analyzed using the
lumi package [73] of R (www.r-project.org) and normalized with RSN nor-
malization [168]. Both datasets were tested for dierentially expressed genes
of normal and sterol-depleted conditions using the Rank Product Test [41].
Signicant genes were determined using a cuto of false positives smaller than
5% (false discovery rate < 5%). Dierentially regulated genes were compared
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Figure 2.3. Workow of data integration and identication of
SREBP target genes. Dierentially expressed genes in sterol-depleted
medium were identied in broblasts and HeLa cells. Promoter regions of dif-
ferentially expressed genes were screened in silico for SREBP binding sites and
genes selected with binding motifs for SREBP. This yielded putative SREBP
target genes which were compared to genes coding for enzymes in cholesterol
biosynthesis and any known relationships to SREBP. Identied binding sites
were compared to ChIP-Seq data from the ENCODE project [65] for SREBP
and NF-Y (ChIP-Seq data for SREBP1a and SREBP2 were taken from a study
by the lab of Michael Snyder at Yale University and NF-YA and NF-YB from
a study by the lab of Kevin Struhl at Harvard and the data was downloaded
from UCSC [236]) and their conservation to chimp and mouse was assessed.
Selected genes were validated experimentally using qRT-PCR and SREBP
knockdown experiments.
to already known genes associated to cholesterol and fatty acid biosynthe-
sis using Gene Ontology terms (www.geneontology.org). The mapping of
associated Gene Ontology terms for each gene was downloaded from NCBI
(Build 36.3) and parsed for the terms sterol, steroid, lipid and fatty acid.
In addition, enrichment of genes encoding for the 22 enzymes necessary for
cholesterol biosynthesis (acly, acas2, acat2, hmgcs1, hmgcr, mvk, pmvk, mvd,
idi1, fdft1, sqle, lss, cyp51a1, tm7sf2, sc4mol, h105e3, hsd17b7, ebp, sc5dl,
dhcr7, dhcr24 ; see [22]) was tested using a Fisher's exact test.
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2.2.2 Genome-wide in silico promoter screen and
identication of genes with SREBP binding sites
Sequences from 10,000 bp upstream to 1,000 bp downstream of the tran-
scription start site for 32,121 human genes were retrieved from NCBI (Build
36.3) (ftp://ftp.ncbi.nlm.nih.gov/). We used a total of 21 position
weight matrices (PWMs) for SREBP1 and its isoforms a and c as well as
7 for SREBP2, 6 for SP1, 5 for NF-Y and its isoforms alpha and beta,
and 4 PWMs for the LXR isoforms LXR-alpha and LXR-beta which were
taken from TRANSFAC (Release 12.1) [183]. The promoter screen using
these position-weight matrices was conducted as described in [227, 294] with
R (http://www.r-project.org). Predicted binding sites with a p-value
below 0.05 were used for our analysis where each PWM binding site corre-
sponds to a binding site of its associated transcription factors. For genes
with predicted SREBP binding sites, binding sites for SP1, NF-Y, and LXR
were determined. Predicted SREBP target genes were compared to already
known genes associated to cholesterol and fatty acid biosynthesis in the same
way as described for dierentially expressed genes (see section 2.2.1). Gene
Ontology enrichment analysis for the identied SREBP target genes was
conducted using topGO [4] with R (http://www.r-project.org) using the
classic algorithm for scoring signicance of GO terms. To correct for multiple
testing, a Benjamini-Hochberg correction [26] was applied. GOterms with a
p-value < 0.05 were taken for further considerations. Additional biological
roles of identied SREBP target genes were also identied using topGO [4]
with R (http://www.r-project.org) using the weight algorithm for scor-
ing signicance of GO terms. GOterms with a p-value < 0.05 were taken for
further considerations.
2.2.3 Identication of putative SREBP target genes
and comparison to existing sequence data of
chromatin immunopreciptation screens (ChIP-
Seq)
We compared predicted SREBP target genes to ChIP-Seq data from the EN-
CODE project [65] for SREBP and NF-Y. ChIP-Seq data for SREBP1a and
SREBP2 were taken from a study in HepG2 cells by the lab of Michael Sny-
der at Yale University and NF-YA and NF-YB from a study in K-562 cells by
the lab of Kevin Struhl at Harvard. For sterol deprivation, HepG2 cells were
cultured with pravastatin (2 M; Sigma) in DMEM with 0.5% BSA for 16 h.
The data was downloaded from UCSC [236]. Genome coordinates of peak hits
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were compared to gene annotations (NCBI Build 36.3) and target genes were
determined using the same settings as for the in silico promoter screen. Bind-
ing sites occurring within a range of -10kb and +1kb of the annotated tran-
scription start site of a gene were included in the analysis. The determined
genes were then compared to the list of identied putative SREBP target
genes. Predicted target sites were also analyzed for evolutionary conserva-
tion. To determine the conservation of binding sites of the predicted SREBP
target genes, we analyzed pair-wise alignments between human and mouse,
and human and chimp, respectively. Chained and netted pair-wise align-
ments of human (UCSC version hg18) with chimp (UCSC version panTro2)
and mouse (UCSC version mm9) were downloaded from UCSC [236] in the
axtNet format (ftp://hgdownload.cse.ucsc.edu/). Conserved regions be-
tween human-chimp and human-mouse were determined by the given aligned
regions in the alignment les. Predicted binding sites for SREBP were com-
pared to the identied conserved regions and taken as conserved if binding
sites occurred in conserved regions. To compare the conservation of SREBP
binding sites to the conservation of all TF binding sites in the promoter
sequences of the predicted SREBP target genes, the number of conserved
bindings sites for all transcription factors in chimp and mouse was deter-
mined in the same way as described for SREBP. A one-sided Wilcoxon test
was conducted to assess the signifcance level of the conservation of SREBP
binding sites compared to the number of conserved binding sites for all tran-
scription factors.
2.2.4 Cell culture and sterol depletion
HeLa kyoto cells and human broblasts (KOA-1) were plated onto 100
mm cell culture dishes (SPL life sciences) and cultivated at 37 C, 5%
CO2 in either DMEM/ 1g/l Glucose/with L-Glutamine (PAA), 1%
(v/v) Penicillin/Streptomycin (100x) (PAA) and 5% FBS (Biochrom)
(HeLa cells) or DMEM/ 1g/l Glucose/ with L-Glutamine, 1% (v/v)
Penicillin/Streptomycin (100x), 1% (v/v) Amphotericin B (250 g/ml)
(PAA) and 10% FBS (KOA1). After reaching a cell density of 60%,
cells were either cultivated in control media or sterol depleted media
without FBS but 0.5 % LDS (Pan Biotech) (HeLa cells) or 5% LDS
(KOA-1). After 96 hours sterol depleted cells were additionally treated with
1% (w/v) (2-Hydroxypropyl)--cyclodextrin (HPCD, Sigma) for 3 hours
and afterwards cultivated for additional 3 hours in sterol depleted media.
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2.2.5 siRNA treatment
For SREBP knockdown experiments HeLa cells were plated onto 100 mm
cell culture dishes and cultivated at 37 C, 5% CO2 in DMEM/ 1g/l Glu-
cose/ with L-Glutamine and 5% FBS one day before siRNA treatment.
Transfection was performed with OligofectamineTMReagent (Invitrogen) us-
ing a negative control siRNA (Silencer R Select 4390843, Ambion), siRNA
against srebf1 (Silencer R Select 4392420, Ambion), srebf2 (Silencer R Select
4390824, Ambion) or both. Medium was changed 24 hours after transfection
and cells were either cultivated in control or sterol depleted media, respec-
tively. 48 hours after transfection sterol depleted cells were treated with
1% HPCD as described in section 2.2.4.
2.2.6 RNA isolation and quantitative real-time PCR
For gene expression experiments via qRT-PCR RNA was isolated with the
InviTrap R Spin Cell RNA Mini Kit (Invitek). RNA was then reverse tran-
scribed by RevertAidTMH Minus m-MuL V Reverse Transcriptase (200 u/l)
(Fermentas) using random primers (Invitrogen). QRT-PCR was performed
with Power SYBR RGreen (Applied Biosystems) using a 7500 Fast Real-
Time PCR System (Applied Biosystems). Three or four independent RNA
samples were analyzed for each gene and dierential expression was calcu-
lated in relation to housekeeping gene rpl19.
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Results
3.1 Identication of spatio-temporal specic
regulatory modules
3.1.1 Identifying regulatory modules
To identify regulatory modules, we performed a genome-wide screen for tran-
scription factor binding sites using position weight matrices (PWM-scans) for
all annotated human genes and transcription factors [227, 294]. Figure 2.1
depicts the workow of the method. The sequence upstream and down-
stream (+/- 100 base pairs) of the annotated transcription start site (TSS)
was termed promoter region whereas the studied enhancer region was further
upstream of the TSS (2,000-10,000 base pairs upstream). To identify inter-
acting transcription factors at promoters and enhancers, we selected pairs
of co-occurring transcription factor binding sites in a dened window at the
promoter and enhancer region for each gene, respectively. We then com-
bined identied pairs of co-occurring transcription factors at the promoter
and enhancer region for each gene to analyze combinations of promoter and
enhancer interactions. These combinations were termed regulatory modules.
After ltering (see section 2.1.3), we identied 129 regulatory modules bind-
ing at 340 genes. To generalize our investigations, we repeated the analysis
and identied regulatory modules also for mouse and rat. Regulatory mod-
ules for mouse and rat showed similar results when applying the same settings
as for human (see Table 3.1).
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Table 3.1. Overview of the number of identied transcriptional reg-
ulators for dierent organisms.
Human Mouse Rat
Regulatory
elements
Genes
Regulatory
elements
Genes
Regulatory
elements
Genes
Transcription
factors (TFs)
132 32121 123 33033 132 27110
TF pairs at
promoters
111 3007 77 1931 74 1891
TF pairs at
enhancers
579 11172 418 10985 585 8326
Regulatory
modules
129 340 113 311 28 134
3.1.2 Identied regulatory modules regulate spatio-
temporal gene expression in development
To investigate time- and tissue-specic regulatory roles of the identied reg-
ulatory modules in development, we analyzed time series of gene expression
proles of embryonic development in mouse and embryonic stem cell dier-
entiation in human cells.
Human stem cell dierentiation
We selected gene expression studies from a broad range of dierent human
stem cells of dierent origin. Each study was regarded as tissue-specic. For
better comparison among the dierent studies, we grouped time points for
each gene expression study into three distinct time intervals we termed early,
mid, and late expression. For each gene expression study, we identied dier-
entially expressed genes at these time intervals and determined their respec-
tive regulation by transcription factors, pairs of co-occurring transcription
factors and regulatory modules employing enrichment analyses (see chapter
2). We compared the number of enriched tissues and time intervals for single
transcription factors, pairs of co-occurring transcription factors and regula-
tory modules. Strikingly, regulatory modules showed the highest tissue and
temporal specicity. Figure 3.1 shows the results for human stem cells. Only
16% of transcription factors were specic for a single tissue whereas 76% of
pairs of co-occurring transcription factors in promoter regions, 77% of pairs of
co-occurring transcription factors in enhancer regions and 79% of regulatory
modules showed specicity for a single tissue. Temporal specicity was even
more distinctive. Whereas only 40% of the studied transcription factors were
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Figure 3.1. Tissue and temporal specicity for each regulatory el-
ement during dierentiation of human stem cells. The number of tis-
sues versus the number of time intervals is plotted for A transcription factors,
B pairs of co-occurring transcription factors in promoter regions, C pairs of
co-occurring transcription factors in enhancer regions, and D regulatory mod-
ules. The percentage of the dierent regulatory elements is indicated at each
entry in the grid (i.e. 9% of transcription factors are specic for a single tissue
and a single time interval). The color also represents the percentage of regula-
tory elements at each point in the grid; bright red indicates a high amount of
regulatory elements whereas light pink indicates a low amount of regulatory
elements at the respective entry.
specic for a single time interval, 79% of pairs of co-occurring transcription
factors in promoter regions and 85% in enhancer regions and even 97% of the
regulatory modules showed specicity for a single time interval in the data
sets of human stem cells (Figure 3.2). Ravasi and coworkers [229] showed
that pairs of transcription factors rather than single transcription factors de-
termine tissue specicity. Surprisingly, the additional temporal specicity of
regulatory modules is obtained by pairs of co-occurring transcription factors
at enhancers (97% for regulatory modules versus 85% for pairs of co-occurring
transcription factors, signicance of the dierence: P = 0.01).
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Figure 3.2. Frequency distribution of the number of time inter-
vals for human stem cell dierentiation. The histograms show the fre-
quency distribution of the number of time intervals forA transcription factors,
B pairs of co-occurring transcription factors in promoter regions, C pairs of
co-occurring transcription factors in enhancer regions, and D regulatory mod-
ules.
Mouse embryonic development
Similar results to the human stem cell dierentiation data sets were ob-
tained for mouse embryonic development. The analysis was conducted in
the same manner as for human stem cell dierentiation. As described in
section 2.1.4, we selected gene expression studies from a broad range of dif-
ferent embryonic mouse tissues of dierent origin. Each study was regarded
as tissue-specic. For better comparison among the dierent studies, we also
grouped time points for each gene expression study into three distinct time
intervals we termed early, mid, and late expression. For each gene expres-
sion study, we identied dierentially expressed genes at these time intervals
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Figure 3.3. Tissue and temporal specicity for each regulatory ele-
ment in the embryonic development of mouse. The number of tissues
versus the number of time intervals is plotted for A transcription factors,
B pairs of co-occurring transcription factors in promoter regions, C pairs of
co-occurring transcription factors in enhancer regions, and D regulatory mod-
ules. The percentage of the dierent regulatory elements is indicated at each
entry in the grid (i.e. 9% of transcription factors are specic for a single tissue
and a single time interval). The color also represents the percentage of regula-
tory elements at each point in the grid; bright red indicates a high amount of
regulatory elements whereas light pink indicates a low amount of regulatory
elements at the respective entry.
and determined their respective regulation by transcription factors, pairs of
co-occurring transcription factors and regulatory modules employing enrich-
ment analyses (see chapter 2). We compared the number of enriched tissues
and time intervals for single transcription factors, pairs of co-occurring tran-
scription factors and regulatory modules. Similarly to the results of human
stem cell dierentiation, regulatory modules showed the highest tissue and
temporal specicity. Figure 3.3 and Figure 3.4 show the results for mouse em-
bryonic development. Whereas 34% of the transcription factors were specic
for a single time interval and 11% for a single tissue, 77% and 52% of pairs
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Figure 3.4. Frequency distribution of the number of time inter-
vals for mouse embryonic development. The histograms show the fre-
quency distribution of the number of time intervals forA transcription factors,
B pairs of co-occurring transcription factors in promoter regions, C pairs of
co-occurring transcription factors in enhancer regions, and D regulatory mod-
ules.
of co-occurring transcription factors at promoters, 79% and 58% of pairs at
enhancers, and 89% and 69% of regulatory modules showed specicity for a
single time interval and tissue, respectively.
Enhancers determine temporal specicity
As seen for both mouse embryonic development and human stem cell dier-
entiation, the combinations of regulatory factors at promoters and enhancers
resulted in higher specicity of tissue and temporal regulation during de-
velopment and dierentiation. Concluding, transcription factors binding
at promoters contributed signicantly to tissue-specic regulation whereas
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regulatory factors at enhancers rather accounted for temporal specicity.
To cross-check the specicity of these regulatory modules, we constructed
regulatory modules consisting of combinations of pairs of co-occurring
transcription factors at promoters only and repeated the analysis. Using
the same parameter settings, we identied a limited number of regulatory
modules (n = 12) that did not allow any conclusion about tissue and
temporal specicity. Even increasing the promoter region by a factor of ten
(which resulted in a sucient number of regulatory modules) revealed 83%
of regulatory modules as tissue-specic but only 61% as time-specic. These
results further support the fact that the combinations of promoter-enhancer
interactions establish temporal specicity of gene expression.
3.1.3 Regulatory modules predict temporal gene ex-
pression in development
To identify regulatory modules (combinations of transcription factors) for
temporal specicity, we further analyzed the active regulatory modules dur-
ing human stem cell dierentiation. We learned a classier (of a random
forest) to predict the time interval (now simplied for two categories, early
and late) of dierential expression for each gene based on its regulatory mod-
ules. This way, we were able to predict temporal dierential expression based
on the prole of regulatory modules. Specically, we predicted the combina-
tion of pairs of co-occurring transcription factors in promoter and enhancer
regions, which determine the temporal regulation observed during develop-
ment. The top 10 regulatory modules explaining best temporal specicity are
shown in Table 3.2. TF-groups SP1 (Sp1 transcription factor), EGR1 (early
growth response 1) and E2F1 (E2F transcription factor 1) were the most ob-
served transcription factors occurring in promoter regions, whereas members
of the forkhead box family of transcription factors (FOXI1, FOXJ1, FOXD3,
FOXF1, FOXL1, and FOXA1) and CDX1 (caudal type homeobox 1) were
mostly found at enhancer regions. To validate our results, we performed
a stratied 10 times 10-fold cross-validation and trained with the top 5%
of regulatory modules yielding a considerably good prediction performance
(70% accuracy, 73% sensitivity, 69% specicity). In comparison, pairs of
co-occurring transcription factors at promoters were not sucient to pre-
dict temporal gene expression and failed to detect dierences between the
time intervals (43% accuracy, 21% sensitivity, 76% specicity). These results
support the specicity of the identied regulated modules for temporal gene
expression.
58 CHAPTER 3. RESULTS
Table 3.2. Top ten of the list of identied regulatory modules ex-
plaining temporal specicity for the dierentiation of human stem
cells.
Regulatory modules*
Additional members of the
TF-group
Binding preference+
SP1 SP1 - FOXI1 FOXJ1
SP2, SP3, SP4 (SP1)
FOXD3, FOXF1, FOXF2 (FOXJ1)
TSS-enriched-BS
(SP1)
TSS-depleted-BS
(FOXI1,FOXJ1)
SP1 SP1 - FOXJ1 FOXJ1
SP2, SP3, SP4 (SP1)
FOXD3, FOXF1, FOXF2 (FOXJ1)
TSS-enriched-BS
(SP1)
TSS-depleted-BS
(FOXJ1)
SP1 SP1 - CDX1 FOXA1
SP2, SP3, SP4 (SP1)
CDX2 (CDX1)
FOXA2, FOXA3 (FOXA1)
TSS-enriched-BS
(SP1)
TSS-depleted-BS
(CDX1,FOXA1)
SP1 SP1 - FOXI1 FOXA1
SP2, SP3, SP4 (SP1)
FOXA2, FOXA3 (FOXA1)
TSS-enriched-BS
(SP1)
TSS-depleted-BS
(FOXI1,FOXA1)
EGR1 SP1 - FOXI1 FOXA1
EGR2, EGR3, EGR4 (EGR1)
SP2, SP3, SP4 (SP1)
FOXA2, FOXA3 (FOXA1)
TSS-enriched-BS
(EGR1,SP1)
TSS-depleted-BS
(FOXI1,FOXA1)
SP1 SP1 - FOXJ1 FOXJ2
SP2, SP3, SP4 (SP1)
FOXD3, FOXF1, FOXF2 (FOXJ1)
TSS-enriched-BS
(SP1)
TSS-depleted-BS
(FOXJ1,FOXJ2)
SP1 SP1 - FOXL1 FOXL1 SP2, SP3, SP4 (SP1)
TSS-enriched-BS
(SP1)
TSS-depleted-BS
(FOXL1)
E2F1 E2F1 - FOXL1 FOXA1
E2F2, E2F3, E2F4, E2F5, E2F7,
TFDP1 (E2F1)
FOXA2, FOXA3 (FOXA1)
TSS-enriched-BS
(E2F1)
TSS-depleted-BS
(FOXL1,FOXA1)
E2F1 EGR1 - FOXJ2 FOXL1
E2F2, E2F3, E2F4, E2F5, E2F7,
TFDP1 (E2F1)
EGR2, EGR3, EGR4 (EGR1)
TSS-enriched-BS
(E2F1,EGR1)
TSS-depleted-BS
(FOXJ1,FOXL1)
EGR1 SP1 - CDX1 FOXI1
EGR2, EGR3, EGR4 (EGR1)
SP2, SP3, SP4 (SP1)
CDX2 (CDX1)
TSS-enriched-BS
(EGR1,SP1)
TSS-depleted-BS
(CDX1,FOXI1)
* The rst two transcription factors were identied at promoters, the last two at enhancers.
+ TSS-enriched-BS: Transcription factors with binding sites predominantly around the TSS;
TSS-depleted-BS: transcription factors with a depletion of binding sites at the TSS.
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3.1.4 Transcription factors show distinct binding site
distributions for promoter and enhancer regions
To identify dierences among transcription factors binding preferentially ei-
ther at promoter or enhancer regions of the identied regulatory modules,
we analyzed the distributions of binding sites for all transcription factors
with respect to the annotated transcription start site (TSS). Interestingly,
we identied three dierent binding site distributions for the analyzed tran-
scription factors. Figure 3.5 shows exemplarily the distributions for the TF-
groups SP1, FOXA1 and TP53 (tumor protein p53). The distribution of
SP1 showed an enrichment of binding sites close to the TSS (Figure 3.5A).
Binding sites with these distributions were termed TSS-enriched-BS, whereas
FOXA1 exhibited a depletion of binding sites at the TSS (TSS-depleted-BS,
Figure 3.5B). We also observed rather uniform distributions for e.g. TP53
(uniformly-distributed-BS, Figure 3.5C). We investigated the motifs of these
three groups and found that transcription factors with TSS-enriched-BS had
binding sites with a higher GC content compared to the other transcrip-
tion factors (P = 8.22E-14). This is consistent with reports that sequences
at TSS are often GC rich [83, 114, 147]. All transcription factors occur-
ring at promoters of the identied regulatory modules had TSS-enriched-BS,
and 91% of the transcription factors at enhancers had TSS-depleted-BS. No-
tably, this tendency was even stronger for the regulatory modules selected by
the classication algorithm (100% TSS-enriched-BS for the promoter pairs
and 100% TSS-depleted-BS for the enhancer pairs of regulatory modules).
When applying the analysis to all transcription factors analyzed, the major-
ity of transcription factors (53%) showed a uniform distribution of binding
sites with no preferential binding position (uniformly-distributed-BS). 21% of
transcription factors were determined to preferentially bind close to the TSS
(TSS-enriched-BS), whereas 26% transcription factors showed a depletion of
binding sites around the TSS (TSS-depleted-BS). Binding preferences for all
transcription factors are shown in Table A.1. It is to note that although pre-
vious studies identied transcription factors with preferential binding close
to the TSS [83, 147, 271, 282, 302, 304], transcription factors showing a de-
pletion of binding sites around the TSS or a uniform binding site distribution
have been noted [83] but have not been quantied so far.
To further distinguish TFs with TSS-enriched-BS from TFs with
TSS-depleted-BS, we determined the ratio (log-ratio) of the number of bind-
ing sites at promoters and enhancers per transcription factor. Binding sites
at the promoter region (+/- 100 bp around the TSS) and the enhancer re-
gion (2,000 bp to 10,000 bp upstream of the TSS) were counted per transcrip-
tion factor for all genes. The number of binding sites was then normalized
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Figure 3.5. Distribution of binding sites for dierent groups of tran-
scription factors. For dierent groups of transcription factors the distri-
bution of binding sites with respect to the transcription start site is shown
exemplarily for the transcription factors SP1, FOXA1, and TP53: A The dis-
tribution for SP1 which represents the distribution of binding sites for tran-
scription factors preferentially binding at the transcription start site (TSS-
enriched-BS), B the distribution of FOXA1 which represents the distribution
of binding sites for transcription factors with a depletion of binding sites at
the TSS (TSS-depleted-BS), and C the distribution for TP53 representing
uniformly distributed binding sites (uniformly-distributed-BS).
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according to the width of the binding region. The log ratio of binding
sites at promoters and enhancers was determined and compared between
transcription factors preferentially binding at the TSS (TSS-enriched-BS)
and transcription factors with a depletion of binding sites close to the TSS
(TSS-depleted-BS). We identied a major dierence between the ratios for
the two classes of transcription factors using a Wilcoxon test. Transcrip-
tion factors with TSS-enriched-BS had signicantly more binding sites at
promoters whereas transcription factors with TSS-depleted-BS had more
binding sites at enhancer regions (P < 2.2e-16, Figure 3.6).
Figure 3.6. Log ratio of binding sites at promoters and enhancers.
The distribution of the log-ratios of binding sites at promoters and enhancers
is shown in red for transcription factors with preferential binding around the
transcription start site (TSS-enriched-BS) and in blue for transcription factors
with a depletion of binding sites at the TSS (TSS-depleted-BS).
3.1.5 Network analysis of transcription factors
To further analyze characteristics of transcription factors with dierent
binding site distributions in promoter and enhancer regions, we constructed
two networks. A link in the networks was set for each pair of co-occurring
transcription factors identied at promoters for the promoter network
and enhancer regions for the enhancer network. Interestingly, in both
networks, the majority of transcription factors with TSS-enriched-BS was
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Figure 3.7. Networks of transcription factor pairs (human). The
network of pairs of co-occurring transcription factors are shown for A the
promoter regions and B the enhancer regions. C A network of transcrip-
tion factors mapped onto a PPI network [16]. Transcription factors showing
preferential binding around the transcription start site (TSS-enriched-BS) are
marked in red, transcription factors with a depletion of binding sites around
the TSS (TSS-depleted-BS) in blue and transcription factors showing no pref-
erential binding (uniformly-distributed-BS) in green. In the promoter network,
transcription factors with TSS-depleted-BS formed a small cluster, including
FOXA1, FOXI1, FOXJ1A, FOXJ2, FOXL1, and CDX2.
adjacent to transcription factors of the same entity (TSS-enriched-BS)
(signicant (P = 0.002) for the promoter network and tendency (P = 0.1)
for the enhancer network). Similarly, transcription factors with TSS-
depleted-BS were preferentially adjacent to transcription factors with
TSS-depleted-BS (P = 0.002 for the promoter network and P = 0.001 for
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Figure 3.8. Distribution of binding site preferences of pairs of co-
occurring transcription factors in the promoter and the enhancer
networks. The number of pairs with specic binding site preferences is
shown in dark gray. To get a null distribution, node labels were permuted
10,000 times and the mean number of TFs pairs with specic binding prefer-
ences determined (light gray). TSS-enriched-BS represent transcription factors
showing preferential binding around the transcription start site, TSS-depleted-
BS transcription factors with a depletion of binding sites at the TSS, and
uniformly-distributed-BS transcription factors showing no preferential bind-
ing. The results for the promoter network are shown in A, the results for the
enhancer network in B.
the enhancer network). In the promoter network, transcription factors
with TSS-depleted-BS formed a small cluster and were not connected to
transcription factors with TSS-enriched-BS. These TSS-enriched-BS tran-
scription factors include FOXA1, FOXI1, FOXJ1A, FOXJ2, FOXL1, and
CDX2. Figure 3.7 shows the networks and Figure 3.8 the distributions of
64 CHAPTER 3. RESULTS
Table 3.3. Overview of network properties.
Promoter network Enhancer network PPI network
TSS-
enriched
TSS-
depleted
TSS-
enriched
TSS-
depleted
TSS-
enriched
TSS-
depleted
Quantity 17 8 23 34 19 19
Connectivity* 50 12 124 64 62 20
Betweenness
centrality*
351.5 0 349.4 1062.4 2055.2 401.3
* For each transcription factor group, the maximum is shown.
transcription factors in the promoter and enhancer networks.
As shown in Table 3.3, most transcription factors in the promoter network
had TSS-enriched-BS (65%), whereas only 24% of transcription factors had
TSS-depleted-BS. To further characterize distinct roles for transcription
factors with dierent binding site distributions, we determined connectivity
and betweenness centrality for each node in the networks. The transcription
factor SP1 with TSS-enriched-BS had the highest connectivity and highest
centrality in the promoter network with a connectivity of 50 and betweenness
centrality of 351.5. In contrast, the highest connectivity of a transcription
factor with TSS-depleted-BS was 12 and the betweenness centrality was zero
for all transcription factors with TSS-depleted-BS. These results supported
the fact that transcription factors with TSS-enriched-BS played a central
role in the promoter network. These transcription factors constituted the
main component of the network (Figure 5A) while transcription factors
with TSS-depleted-BS formed a rather small and separated component. In
contrast, transcription factors with TSS-depleted-BS played a central role
in the enhancer network. These transcription factors constituted the core
of the enhancer network (Figure 5B) with other transcription factors at
its periphery. 44% of the transcription factors in the enhancer network
had TSS-depleted-BS whereas only 29% of the transcription factors had
TSS-enriched-BS. The fork head transcription factor FOXA1 (forkhead
box A1) with TSS-depleted-BS had the highest connectivity (124) and
centrality (1062.4) in the enhancer network. In contrast, the highest connec-
tivity of a transcription factor with TSS-enriched-BS was 64 and the highest
betweenness centrality was 349.4. In addition, we constructed a network of
known transcription factor interactions (physical binding of pairs of tran-
scription factors, obtained from a public repository [16]). Interestingly, the
number of transcription factors with TSS-enriched-BS and TSS-depleted-BS
was balanced (both 23%) and these transcription factors were located rather
at the core of the network (Figure 5C). TBP (TATA box binding protein)
3.2. IDENTIFICATION OF NOVEL PUTATIVE SREBP TARGET GENES 65
with TSS-enriched-BS showed the highest connectivity (62) and betweenness
centrality (2055.2) in the network compared to transcription factors with
TSS-depleted-BS which had a maximum connectivity of 20 and a maximum
centrality of 401.3.
3.2 Identication of novel putative SREBP
target genes
The regulation of cholesterol biosynthesis is one example where transcrip-
tional activation is achieved by the combined action of several transcrip-
tion factors. The key regulator, the sterol regulatory element binding pro-
tein (SREBP), is a weak transcription factor itself and has been shown to
work in co-operation with SP1 and NF-Y [72, 134, 234, 241]. Therefore, we
aimed at identifying novel putative SREBP target genes by integrating in
silico predictions of SREBP target genes with gene expression proling of
cholesterol-depleted cells when SREBP is induced.
3.2.1 Prediction of new putative SREBP target genes
by integrating binding site predictions and gene
expression proling
To determine SREBP target genes we integrated gene expression data of
cholesterol depleted cells and in silico predictions of SREBP target genes.
The workow is shown in Figure 2.3. We conducted gene expression analysis
of two dierent cell lines cultured under control and sterol-depleted condi-
tions. In addition to genome-wide gene expression analysis in HeLa cells [22],
we analyzed a primary human skin broblast cell line from a healthy indi-
vidual. In total, we yielded 189 signicantly dierentially expressed genes,
of which 73 were up- and 116 down-regulated (see Table B.1). Among the
dierentially expressed genes, 42 genes have been described previously to
be functionally relevant for cholesterol biosynthesis and lipid homeostasis.
Of these, 16 genes encode cholesterol biosynthetic enzymes (all genes neces-
sary for cholesterol biosynthesis in human: 22 (see [22])). For example, the
rate-limiting enzyme for cholesterol synthesis is 3-hydroxy-3-methylglutaryl-
coenzyme A reductase (HMGCR) and it was up-regulated in both studies
(P < 2.2e-16 for both studies), with a mean fold change of 4.3 in the HeLa-
cell experiments and 3.5 in the broblast experiments. To rene this list
and to select genes with SREBP binding sites we performed a genome-wide
in silico promoter screen for all human genes with annotated transcription
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start sites (TSS). As SREBP1 and 2 typically cooperate with the transcrip-
tional co-factors SP1 and NF-Y [72, 134, 234, 241], we also screened for bind-
ing motifs of SP1 and NF-Y in the promoter region of the predicted SREBP
target genes. In addition, we considered LXR which is known to regulate
cellular cholesterol and is involved in its eux [234]. Of the 22 human genes
necessary for cholesterol biosynthesis we identied SREBP binding sites for
10 genes, SP1 binding sites for 19 genes, NF-Y binding sites for 15 genes,
and LXR binding sites for 14 genes.
The integration of dierentially expressed genes upon cellular cholesterol de-
pletion and in silico predicted SREBP target genes yielded a total of 99 genes
which are shown in Table 3.4.
Table 3.4. Putative SREBP target genes determined by gene ex-
pression analysis and binding site prediction.
A Genes up-regulated under sterol-depleted conditions
Fibroblasts HeLa cells
Symbol Name pfp1 FC2 pfp1 FC2 SREBP3 SP13 NF-Y3 LXR3
HES6
hairy and
enhancer of split
6 (Drosophila)
0 3.7806 x x x
CPSF1
cleavage and
polyadenylation
specic factor 1,
160kDa
0 2.5922 x x x x
CCNG2 cyclin G2 1.00E-04 2.3832 x x x
SLCO2A1
solute carrier
organic anion
transporter
family, member
2A1
3.00E-04 2.1154 x x x
BHLHE40
basic
helix-loop-helix
family, member
e40
3.00E-04 2.6160 x x
FLVCR1
feline leukemia
virus subgroup C
cellular receptor
1
7.00E-04 2.0854 x x x
TMEM97
transmembrane
protein 97
0.0014 2.6274 0.0017 2.0197 x x x
HSD17B7
hydroxysteroid
(17-beta)
dehydrogenase 7
0.0018 1.9727 x x x
INSIG1
insulin induced
gene 1
0.0019 2.8316 0 3.2167 x x x
MVD
mevalonate
(diphospho)
decarboxylase
0.0023 2.3226 x x x x
MAFB
v-maf muscu-
loaponeurotic
brosarcoma
oncogene
homolog B
(avian)
0.0024 2.3337 x x x
1 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
2 Fold change in broblasts or HeLa-cells
3 x in columns 3-6 indicates predicted binding sites for SREBP, NF-Y, Sp1, and LXR.
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Fibroblasts HeLa cells
Symbol Name pfp1 FC2 pfp1 FC2 SREBP3 SP13 NF-Y3 LXR3
STC1 stanniocalcin 1 0.0028 2.3742 x x x
IDI1
isopentenyl-
diphosphate
delta isomerase 1
0.0028 2.2995 0.0013 2.1098 x x x x
FABP3
fatty acid
binding protein
3, muscle and
heart (mammary-
derived growth
inhibitor)
0.003 2.3738 x x x x
KLF6
Kruppel-like
factor 6
0.0031 3.1659 x x x x
PDGFRB
platelet-derived
growth factor
receptor, beta
polypeptide
0.0035 2.3345 x x x x
SCD
stearoyl-CoA
desaturase
(delta-9-
desaturase)
0.0038 2.1175 0.0011 1.9835 x x x
LPIN1 lipin 1 0.004 2.0214 0.049 1.7186 x x x x
PFKFB4
6-phosphofructo-
2-
kinase/fructose-
2,6-
biphosphatase
4
0.004 2.0521 x x
DHCR7
7-
dehydrocholesterol
reductase
0.0043 1.9957 0.0034 1.883 x x x x
RGS4
regulator of
G-protein
signaling 4
0.0043 2.2216 x x
C17orf59
chromosome 17
open reading
frame 59
0.0045 2.0269 x x x
FDFT1
farnesyl-
diphosphate
farnesyltrans-
ferase
1
0.0072 1.8615 x x x x
MXRA5
matrix-
remodelling
associated 5
0.0086 2.1595 x x x
LDLR
low density
lipoprotein
receptor
0.0089 1.8743 x x x
C20orf20
chromosome 20
open reading
frame 20
0.0095 1.0461 x x
GAS1
growth
arrest-specic 1
0.0096 2.0526 x x x
TP53INP2
tumor protein
p53 inducible
nuclear protein 2
0.0101 1.8091 x x x x
RASD1
RAS,
dexamethasone-
induced
1
0.0117 1.0021 x x
DBC1
deleted in
bladder cancer 1
0.0128 1.906 x x
1 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
2 Fold change in broblasts or HeLa-cells
3 x in columns 3-6 indicates predicted binding sites for SREBP, NF-Y, Sp1, and LXR.
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Fibroblasts HeLa cells
Symbol Name pfp1 FC2 pfp1 FC2 SREBP3 SP13 NF-Y3 LXR3
SLC2A6
solute carrier
family 2
(facilitated
glucose
transporter),
member 6
0.0132 1.8013 x x
TMEM55B
transmembrane
protein 55B
0.0133 1.7783 x x x
TP53INP1
tumor protein
p53 inducible
nuclear protein 1
0.015 1.7629 x x x x
KCNJ2
potassium
inwardly-
rectifying
channel,
subfamily J,
member 2
0.0151 1.8601 x x x
ANGPTL2
angiopoietin-like
2
0.0151 1.7884 x x x x
HSD17B12
hydroxysteroid
(17-beta)
dehydrogenase 12
0.0155 1.7475 x x x
PDGFRA
platelet-derived
growth factor
receptor, alpha
polypeptide
0.0155 1.8534 x x x
SQLE
squalene
epoxidase
0.0157 1.7449 0 2.4489 x x x x
FBLN1 bulin 1 0.0167 2.4985 x x x
PCYT2
phosphate
cytidylyltrans-
ferase 2,
ethanolamine
0.017 1.1331 x x
C3orf54
chromosome 3
open reading
frame 54
0.0175 1.7694 x x x
KLF13
Kruppel-like
factor 13
0.0183 1.669 x x x
FASN
fatty acid
synthase
0.0185 1.7046 1.00E-04 1.8882 x x x
MNT
MAX binding
protein
0.0185 1.678 x x x x
TOB1
transducer of
ERBB2, 1
0.0218 1.7352 x x x x
MYO1D myosin ID 0.0224 1.7072 x x
EPR1
eector cell
peptidase
receptor 1
(non-protein
coding)
0.0275 1.0634 x x x
BIRC5
baculoviral IAP
repeat-containing
5
0.0275 1.0634 x x x
ELOVL6
ELOVL family
member 6,
elongation of
long chain fatty
acids
(FEN1/Elo2,
SUR4/Elo3-like,
yeast)
0.0306 1.6842 x x x
1 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
2 Fold change in broblasts or HeLa-cells
3 x in columns 3-6 indicates predicted binding sites for SREBP, NF-Y, Sp1, and LXR.
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Fibroblasts HeLa cells
Symbol Name pfp1 FC2 pfp1 FC2 SREBP3 SP13 NF-Y3 LXR3
DNAJB9
DnaJ (Hsp40)
homolog,
subfamily B,
member 9
0.0309 1.6304 x
RORB
RAR-related
orphan receptor
B
0.0325 1.6022 x x x
ZCCHC14
zinc nger,
CCHC domain
containing 14
0.0349 1.6118 x x x
FAM189B
family with
sequence
similarity 189,
member B
0.0364 1.6427 x x
MYO10 myosin X 0.0377 1.5884 x x x
SLIT3
slit homolog 3
(Drosophila)
0.038 1.6017 x x x
SAT1
spermidine/spermine
N1-
acetyltransferase
1
0.0381 1.4897 x x x x
FRMD8
FERM domain
containing 8
0.0392 1.6735 x x x
MVK
mevalonate
kinase
0.0399 1.6572 x x
ZC3H12A
zinc nger
CCCH-type
containing 12A
0.0415 1.5342 x x x
SLC26A6
solute carrier
family 26,
member 6
0.0415 1.5668 x x x x
IER5L
immediate early
response 5-like
0.0419 1.5482 x x x
SLC2A3P1
solute carrier
family 2
(facilitated
glucose
transporter),
member 3
pseudogene 1
0.0426 1.6067 x x
DDIT4
DNA-damage-
inducible
transcript 4
0.0444 1.1515 x x x x
HCFC1R1
host cell factor
C1 regulator 1
(XPO1
dependent)
0.0458 1.5468 x x
GP1BB
glycoprotein Ib
(platelet), beta
polypeptide
0.0462 1.5687 x x x
SNAI1
snail homolog 1
(Drosophila)
0.0474 1.5163 x x x
MSX1 msh homeobox 1 0.0485 1.4492 x x x
CXXC5
CXXC nger
protein 5
0.0495 1.5027 x x x
1 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
2 Fold change in broblasts or HeLa-cells
3 x in columns 3-6 indicates predicted binding sites for SREBP, NF-Y, Sp1, and LXR.
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B Genes down-regulated under sterol-depleted conditions
Fibroblasts HeLa cells
Symbol Name pfp1 FC2 pfp1 FC2 SREBP3 SP13 NF-Y3 LXR3
CDC20
cell division cycle
20 homolog (S.
cerevisiae)
0 0.3398 x x
LOC285556
hypothetical
protein LOC285556
0 0.6027 x
PTGES3
prostaglandin E
synthase 3
(cytosolic)
5.00E-04 0.9244 x x x
CXCR2
chemokine (C-X-C
motif) receptor 2
0.0117 0.6894 x x x
ID2
inhibitor of DNA
binding 2,
dominant negative
helix-loop-helix
protein
0.0142 0.4843 0 0.463 x x
MAML2
mastermind-like 2
(Drosophila)
0.0157 0.5794 x x
ACTC1
actin, alpha,
cardiac muscle 1
0.0167 0.4843 x x
F3
coagulation factor
III
(thromboplastin,
tissue factor)
0.0192 0.4966 x x x
SPOCD1
SPOC domain
containing 1
0.0194 0.4696 x x
EDN2 endothelin 2 0.0195 0.5874 x x
S100P
S100 calcium
binding protein P
0.0207 0.4455 x x
CRIP1
cysteine-rich
protein 1
(intestinal)
0.0208 0.5225 x x
TSC22D2
TSC22 domain
family, member 2
0.0209 0.5632 x x x
NTF3 neurotrophin 3 0.0218 0.5795 x x x
TRIP13
thyroid hormone
receptor interactor
13
0.0226 0.5103 x x x x
KLF2
Kruppel-like factor
2 (lung)
0.0228 0.5312 x x x
IQGAP3
IQ motif
containing GTPase
activating protein
3
0.0236 0.531 x x
AXL
AXL receptor
tyrosine kinase
0.0239 0.5541 x x x
PRC1
protein regulator
of cytokinesis 1
0.0242 0.5529 x x
PMP22
peripheral myelin
protein 22
0.0274 0.4008 x x
GBP3
guanylate binding
protein 3
0.0276 0.5946 x x
CDC42EP3
CDC42 eector
protein (Rho
GTPase binding) 3
0.0303 0.614 0.0457 0.5798 x x
1 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
2 Fold change in broblasts or HeLa-cells
3 x in columns 3-6 indicates predicted binding sites for SREBP, NF-Y, Sp1, and LXR.
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Fibroblasts HeLa cells
Symbol Name pfp1 FC2 pfp1 FC2 SREBP3 SP13 NF-Y3 LXR3
ASPM
asp (abnormal
spindle) homolog,
microcephaly
associated
(Drosophila)
0.0329 0.6177 x x
CEP55
centrosomal
protein 55kDa
0.0334 0.6256 x x x x
DUSP1
dual specicity
phosphatase 1
0.0336 0.5624 x x x
OXTR oxytocin receptor 0.0336 0.6168 x x
TIPARP
TCDD-inducible
poly(ADP-ribose)
polymerase
0.034 0.5414 x x
CA12
carbonic anhydrase
XII
0.0345 0.6156 x x x x
RPL29
ribosomal protein
L29
0.0428 0.6387 x x x
UBXN1
UBX domain
protein 1
0.0442 0.7756 x x x
GADD45B
growth arrest and
DNA-damage-
inducible,
beta
0.0465 0.6555 x x x
1 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
2 Fold change in broblasts or HeLa-cells
3 x in columns 3-6 indicates predicted binding sites for SREBP, NF-Y, Sp1, and LXR.
An enrichment analysis for Gene Ontology terms identied mainly cholesterol
and lipid related biological processes (Table 3.6). 21 of the identied 99 genes
have been previously associated to cholesterol or fatty acid metabolism and
genes encoding cholesterol biosynthetic enzymes were enriched among the
identied SREBP target genes when compared to all genes for cholesterol
biosynthesis (P = 7.542e-11), yielding 78 novel putative SREBP target genes.
Many of the novel identied SREBP target genes are involved in cellular
processes such as cell proliferation (pdgfra, pdgfrb, gas1,mnt, tob1, slit3, msx1,
cdc20, cxrcr2, id2, edn2, pmp22 ) and cell cycle (ccng2, gas1, dbc1, tp53inp1,
mnt, birc5, prc1, cdc20, id2, ppp1r14d, cep55, gadd45b), are involved in the
regulation of transcription or are transcription factors themselves (mafb, klf6,
klf13, msx1, maml2, ntf3 ).
3.2.2 Comparison of identied target genes to se-
quencing results from chromatin immunoprecip-
itations (ChIP-Seq)
A comparison with ChIP-Seq data from the ENCODE project [65, 235] for
SREBP1a and SREBP2 by the lab of Michael Snyder at Yale University and
NF-YA and NF-YB by the lab of Kevin Struhl at Harvard showed a high
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Table 3.6. Identied Gene Ontology terms for the 99 identied
putative SREBP target genes.
GO ID GO Term Annotated Signicant Expected P-value
GO:0008610 lipid biosynthetic process 188 15 2.43 8.75E-05
GO:0016126 sterol biosynthetic process 17 6 0.22 0.0002
GO:0006694
steroid biosynthetic
process
47 8 0.61 0.0002
GO:0008203
cholesterol metabolic
process
47 8 0.61 0.0002
GO:0016125 sterol metabolic process 49 8 0.63 0.0002
GO:0006695
cholesterol biosynthetic
process
14 5 0.18 0.0007
GO:0008202 steroid metabolic process 107 10 1.38 0.0010
GO:0008299
isoprenoid biosynthetic
process
8 4 0.1 0.0015
GO:0006629 lipid metabolic process 425 18 5.49 0.0047
GO:0048008
platelet-derived growth
factor receptor signaling
pathway
12 4 0.16 0.0087
GO:0008283 cell proliferation 575 20 7.43 0.0205
GO:0042127
regulation of cell
proliferation
414 16 5.35 0.0389
overlap with our predicted SREBP target genes. Using the same restrictions
as for our in silico analysis, the ENCODE data set comprised 34 genes of our
identied putative SREBP target genes and 55 NF-Y target genes. Table B.3
indicates all predicted binding sites for the 99 identied SREBP target genes
as well as identied binding sites for SREBP and NF-Y of the ENCODE
data set. Several of the predicted SREBP and NF-Y binding sites showed a
high overlap with the identied ENCODE binding sites.
To analyze the conservation of binding sites of the predicted SREBP tar-
get genes, we employed pair-wise alignments between human, mouse and
chimp, respectively. Interestingly, most of the predicted binding sites were
conserved between human, mouse and chimp. 96% of the predicted SREBP
target sites were conserved between human and chimp (compared to 94% of
binding sites of all TFs), whereas 68% of the SREBP target sites were con-
served between human and mouse (see Table B.4). In comparison, signif-
icantly less binding sites of all transcription factors (58%) were conserved
between human and mouse in the upstream regions of the predicted SREBP
target genes (P = 0.0151).
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3.2.3 Experimental Validation of predicted SREBP
target genes
For validation of our results we selected ten out of the 78 putative new
SREBP target genes which were marginally described in association with
cholesterol in the literature and mainly up-regulated at cholesterol deple-
tion and performed qRT-PCR experiments. First, we analyzed the expres-
sion levels of c17orf59, cpsf1, gbp3, hes6, klf6, klf13, mafb, slc2a6, tmem55b,
and tob1 in human broblasts and HeLa cells at control and sterol-depleted
growth conditions. The LDL receptor was used as a positive control and
was signicantly up-regulated under sterol-depleted conditions. Besides this,
also c17orf59, hes6, slc2a6, tmem55b, and tob1 were up-regulated at sterol-
depleted growing conditions in both cell lines. klf6, mafb, and klf13 were only
up-regulated in human broblasts whereas gbp3 showed an up-regulation in
HeLa cells. Only for one (cpsf1 ) out of the ten genes chosen for valida-
tion, we were not able to see any up-regulating eect under sterol-depleted
growth conditions (see Table 3.7). c17orf59, slc2a6, tmem55b, hes6, and
Figure 3.9. Gene expression in sterol-depleted HeLa cells upon
siRNA knockdown of SREBP. In addition to the ve candidate SREBP
target genes, RPL19 and LDLR were used as negative and positive control,
respectively. Signicance of the results after SREBP knockdown are indicated
by * (P < 0.05) and *** (P < 0.001). Knockdown experiments were conducted
by Jessica Schilde.
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Table 3.7. Gene expression levels of ten putative new SREBP target
genes under sterol-depleted growth conditions in human broblasts
and HeLa cells.
Fibroblasts HeLa cells
Symbol Name ratio* SE+ p-value# ratio* SE+ p-value#
LDLR
low density lipoprotein
receptor
5.9 1.01 *** 3.34 1.63 *
SLC2A6
solute carrier family 2
(facilitated glucose
transporter), member 6
4.50 2.36 3.73 1.63
TMEM55B transmembrane protein 55 B 3.43 1.00 2.41 1.39
TOB1 transducer of ERBB2, 1 3.36 2.07 2.31 0.98
C17orf59
chromosome 17 open reading
frame 59
1.86 0.21 * 1.68 0.49
HES6
hairy and enhancer of split 6
(Drosophila)
1.73 0.49 1.82 1.38
KLF6 Kruppel-like factor 6 4.77 1.20 * 1.65 1.93
MAFB
v-maf musculoaponeurotic
brosarcoma oncogene
homolog B (avian)
4.27 0.94 * 0.78 0.69
KFL13 Kruppel-like factor 13 2.66 0.83 0.98 0.32
GBP3 guanylate binding protein 3 1.18 0.16 2.99 2.75
CPSF1
cleavage and polyadenylation
specic factor 1, 160kDa
0.88 0.26 1.03 0.17
* ratio between Ct (cycle threshold) values with regard to RPL19
+ standard error
# * p-value < 0.05, *** p-value < 0.001.
tob1 (up-regulated in both cell systems) were selected for further analy-
sis. To nd out if the expression of these genes was dependent on SREBP,
we analyzed HeLa cells in sterol-depleted conditions and treated them with
interference constructs knocking down SREBP1 and SREBP2, each respec-
tively, and mutually. This was compared to a mock treatment (control)
and the expression of the putative target was quantied (using qRT-PCR).
The results are shown in Figure 3.9. Four out of these ve putative new
SREBP target genes showed a much lower mRNA expression level in sterol
depleted cells after SREBP knockdown compared to the control evidencing
their regulatory dependency on SREBP. c17orf57 and slc2a6 showed a re-
duced expression level after SREBP1 as well as SREBP2 knockdown. In turn,
tmem55b and hes6 expression were only slightly reduced by SREBP1 knock-
down but signicantly reduced when SREBP2 was knocked down indicating
tmem55b and hes6 having been controlled solely by SREBP2 and c17orf59
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and slc2a6 having been regulated by both transcription factors. This evi-
denced tmem55b, c17orf59, hes6, and slc2a6 to be novel potential SREBP
target genes, identied by the integration of transcription factor binding site
predictions and gene expression proles from cells in conditional cholesterol
media.

Chapter 4
Discussion
4.1 Identication of spatio-temporal specic
regulatory modules
It was suggested previously that combinations of dierent complexes of tran-
scription factors oer a plethora of specic gene expression proles [164].
Here, we identied in silico regulatory modules consisting of combinations
of transcription factors binding at promoters and enhancers that determine
specic tissue dependent and temporal regulation of gene expression during
mouse embryonic development and human stem cell dierentiation. In addi-
tion to tissue-specic regulation established by pairs of transcription factors
as shown previously [229], we now also demonstrated that regulatory mod-
ules consisting of pairs of transcription factors at promoters and enhancers
regulate the progression of gene expression patterns during development and
dierentiation. Furthermore, we found that these enhancer sites were rather
depleted of Guanin-Cytosin (CpG). It was shown recently, that methylation-
modications of CpG-regions are a major regulation mechanism during de-
velopment [36, 159, 207]. Enhancer regions therefore may contribute to a
more constitutive regulation program during development which is rather
independent from these methylation-modications.
The identication of in silico transcription factor binding sites using
PWMs can lead to a large number of false positives with no information
about actual functional binding [284]. We addressed this issue by using clus-
tering of binding sites as well as including conservation of binding sites and
dismissed binding sites occurring only in a small number of genes. Addi-
tionally, we incorporated gene expression data into our analysis to identify
transcription factors, combination of transcription factors, and regulatory
modules that are \active" in a specic tissue at a specic time interval.
78 CHAPTER 4. DISCUSSION
Analyzing the identied regulatory modules revealed a number of tran-
scription factors binding preferentially either at promoters or enhancers. For
human stem cell dierentiation, we identied SP1 to preferentially bind
at promoters. Although SP1 is ubiquitously expressed and regulates gene
expression of many constitutively expressed genes [97, 129], its expression
was shown to change at dierent developmental stages and in dierent cell
types, suggesting specic roles in distinct developmental processes [238]. As
SP1-null mice died prenatal, SP1 was shown to be essential for mouse em-
bryonic development [177].
In contrast, members of the FOX (forkhead box) family of transcription
factors had binding sites preferentially located at enhancers of the identied
regulatory modules providing temporal specicity during human stem cell
dierentiation. FOX transcription factors have been identied to bind at
enhancers in a number of studies [58, 63, 71, 105, 186, 303]. FOX proteins
are substantial in a variety of cellular processes including development, dif-
ferentiation, proliferation, apoptosis, and migration [197]. As FOX proteins
are regulators for a multitude of biological processes, their deregulation can
contribute signicantly to tumorigenesis and cancer progression [197]. Vari-
ous members of this family have been identied previously to be implicated
in development [9, 30, 42, 60, 89, 125, 152, 155, 157, 217, 275, 289, 293].
The CDX family was another group of transcription factors we identied
at enhancers of our regulatory modules. cdx genes are closely related to
the Hox cluster and are expressed during embryonic development and gut
morphogenesis [24]. CDX2 is specically required during early development
and cdx2 -null mice are nonviable as the blastocyst fails to implant into the
uterus [266].
Chromatin loops can overcome large distances between long-range en-
hancers and proximal promoters and may lead to false positive hits at pro-
moter regions when screening promoters with ChIP-chip assays [118, 196].
So far, most ChIP sequencing studies neglect to assess indirect binding of
transcription factors. However, it was shown for HNF4A (hepatocyte nu-
clear factor 4, alpha) that identied binding sites at the promoter occurred
mainly at distal regulatory elements [226]. Our results support the fact that
key transcription factors bind preferentially at either promoters or enhancers
and that the interactions between those elements are crucial for specic gene
regulation. Therefore, indirect binding is a central issue that cannot be ne-
glected in prospective transcription factor binding site analyses and speci-
cally when analyzing ChIP-chip and ChIP-Seq experiments.
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4.2 Identication of novel putative SREBP
target genes
Cholesterol biosynthesis in mammals is one example of combinatorial tran-
scriptional regulation. Prediction of SREBP binding sites and its most com-
mon co-factors SP1 and NF-Y allowed the identication of novel potential
target genes of SREBP and gained new insights into the regulation of choles-
terol biosynthesis. Candidate genes were identied by genome-wide gene
expression analyses of sterol-depleted cultured cells in two very distinct hu-
man cell lines. To further minimize the number of false positives, we selected
genes with in silico predicted binding sites for SREBP and its most commonly
co-occurring transcription factors SP1, NF-Y, and LXR. Genes encoding
cholesterol biosynthetic enzymes were enriched among the identied genes
indicating that our integrated approach suited well to identify also novel
SREBP target genes. In addition, comparisons to binding sites of SREBP
and NF-Y identied by ChIP-Seq experiments revealed a high overlap to our
in silico predictions. We identied a number of genes that may constitute
SREBP target genes and play substantial roles in cholesterol metabolism and
specically, cholesterol's control of central cellular decisions. We identied
78 putative SREBP target genes which have not previously been linked to
processes in which cholesterol is involved. Of these, we selected ten genes
for experimental validation. For most of these genes, we validated their up-
regulation in response to cholesterol-depletion. Four of these genes (slc2a6,
tmem55b, hes6, and c17orf59 ) showed distinct down-regulation in response
to SREBP knockdown indicating their regulatory control by SREBP.
Of the validated genes, slc2a6 showed the highest eect of both SREBP1
and SREBP2 knockdowns. It functions as a sugar-transport facilitator with
glucose-transporter activity, though its specic function and stimulus has
not yet been identied [276]. Glucose supports absorption and transport
of cellular cholesterol [230] and SREBP1c has been shown to be sensitive
to high levels of carbohydrates such as glucose [119]. Ravid and coworkers
showed that high extracellular glucose concentration had a positive eect
on the regulation of cholesterol transport [230]. This treatment caused also
an increase in protein expression of NPC1L1 and CD36 which are involved
in cholesterol uptake [230]. It is to note that NPC1L1 is similar to NPC1
which loss-of-function causes the NPC disease 1 and is similarly involved in
cholesterol uptake and tracking [7, 69]. Interestingly, in this study, protein
levels of SREBP2 were decreased whereas LXR levels increased due to high
glucose concentrations [230]. Taken Ravid et al's, Horten et al's, and our
ndings together comparing SREBP1 and SREBP2, we speculate that two
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distinct mechanisms of cholesterol uptake are regulated by SREBP2 and
SREBP1, respectively, enhancing cholesterol/glucose co-transport (rather
SREBP1 regulated) and direct uptake via the LDL receptor (rather SREBP2
regulated). In any way, SLC2A6 may use the uptake of glucose to support
uptake of cholesterol into the cell.
Chromosome 17 open reading frame 59 (C17orf59) has been previously
identied as a potential regulator of cholesterol [22] and demonstrated a
decrease in expression after SREBP knockdown. It is an uncharacterized
protein coding gene that requires further functional analysis.
tmem55b also showed a decrease in expression after SREBP knockdown
(predominantly after knockdown of SREBP2). It catalyzes the hydrolysis of
phosphatidylinositol 4,5-bisphosphate (PtdIns-4,5-P2) to phosphatidylinosi-
tol 5-phosphate (PtdIns-5-P) and appears to aect the lysosomal degradation
of internalized plasma membrane receptors [277]. PtdIns-4,5-P2 is involved
in the regulation of signal transduction, exocytosis/endocytosis, actin dy-
namics, and ion channel and transport function [212, 268]. After cholesterol
depletion, PtdIns-4,5-P2 levels were decreased in the plasma membrane [150]
and the organization of PtdIns-4,5-P2 in the plasma membrane were dis-
rupted [219]. It is reasonable that in physiological conditions, high choles-
terol levels are accomplished with high internalization of LDL which needs
to be lysosomal degraded and a regulation of this feedback mechanism is
mediated by SREBP. Interestingly, increasing levels of PtdIns-5-P have been
shown to mediate p53-dependent apoptosis [313]. In this context, choles-
terol depletion causes SREBP induction, which causes PtdIns-5-P and p53
mediated apoptosis. We found further links of our detected SREBP target
genes to the cellular decision of apoptosis/cell cycle arrest and prolifera-
tion. Specically, HES6, GBP3 and TOB1 showed up-regulation in cells in
cholesterol depleted medium and all have been reported for distinctively anti-
proliferative eects [79, 108, 171, 180, 237]. Reduced cholesterol may result
in a stress response that is mediated by SREBP diminishing proliferation
and inducing apoptosis.
Our integrated approach has revealed new potential SREBP target genes
being functionally relevant to cellular regulation mediated by cholesterol to
control metabolism and signaling in health and disease.
4.3 Outlook
Time- and tissue-specic regulation of gene expression is central not only
during development but in all processes of a cell in an organism. Here, we
identied regulatory modules that determined specic gene regulation during
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development and revealed distinct binding site distributions for transcription
factors binding preferentially at promoter or enhancer regions. The in silico
identication of combinations of transcription factors binding at promoters
and enhancers yielded generic insights into the temporal regulation of gene
expression and improved our understanding of enhancer function.
The identied interactions of transcription factors identied in the reg-
ulatory modules require now experimental validation in a time- and tissue-
specic manner. Knockdown experiments in embryonic mice can demon-
strate the importance of a distinct transcription factor in a specic tissue at
a specic time point. Another option is the use of uorescent dyes (e.g. by
uorescence in situ hybridization) to demonstrate the activity of a distinct
transcription factor at a specic time point in a specic tissue.
Although we applied stringent parameters we were able to identify a num-
ber of interesting regulatory modules. These regulatory modules were dened
to consist of four transcription factors in total, with two transcription factors
each binding either at a promoter region or an enhancer region, respectively.
It remains to analyze the interactions between the transcription factors bind-
ing at the promoter and the transcription factor binding at the enhancer
region in more detail and thereby uncover additional co-factors involved in
the regulation of development and dierentiation.
Another interesting aspect is the hypothesis that tumorigenesis resembles
embryonic development and many key regulators in development have been
shown to be implicated in tumor progression, see e.g. [70, 95, 161, 221]. It
is therefore intriguing to apply the identied regulatory modules to tumor
samples to uncover key regulators in tumorigenesis that will improve our
understanding of tumor progression.
In addition, it has become clearer that histone modications play an
important role in transcriptional regulation [115]. The combination of the
predicted regulatory modules together with histone marker maps at promot-
ers and enhancers might elucidate further insights into the regulatory impact
of both mechanisms.
We employed combinatorial promoter analyses of SREBP and known co-
factors, used gene expression data, and identied new putative SREBP target
genes. Further analyses may reveal the exact mechanism by which the iden-
tied SREBP target genes are involved in cholesterol homeostasis. Their
detailed mechanism may improve our understanding of cholesterol related
diseases, such as Familal Hypercholesterolemia and Niemann-Pick Disease
Type C, when cholesterol uptake is impaired. Further experiments are cur-
rently conducted to elucidate the function of C17orf59 and TMEM55B.
Although we identied putative SREBP target genes that have dierential
regulation upon sterol-depletion and were able to validate a small number of
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genes in functional experiments, a direct inuence of SREBP remains yet to
be shown. Reporter assays using the upstream sequence of the gene under
consideration upon induction of SREBP might help excluding any indirect
eects of SREBP.
Interestingly, SREBP binding sites were not predicted for all genes known
to be involved in cholesterol biosynthesis. However, these predictions can
only be as good as the existing known binding motifs and SREBP might bind
to additional, yet unknown binding motifs. Scanning upstream sequences of
the identied putative SREBP target genes for over presented short sequences
might identify further binding motifs and transcription factors involved in the
regulation of cholesterol biosynthesis.
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Appendix A
Identication of
spatio-temporal specic
regulatory modules
Table A.1. Grouping of transcription factors according to common
PWMs.
Representative TF TFs within the group
Binding
preference
AFP1 AFP1
uniformly-
distributed-BS
AIRE AIRE TSS-depleted BS
Alx-4 Alx-4
uniformly-
distributed-BS
aMEF-2 aMEF-2, MEF2A-isoform1, MEF-2DAB TSS-depleted BS
AML1
AML1, AML2, AML1b, AML1c, AML1a,
PEBP2beta, AML3, PEBP2alpha, AML3-isoform2,
AML3-isoform 1
uniformly-
distributed-BS
AP-2alphaA AP-2alphaA, AP-2gamma, AP-2alphaB, AP-2beta TSS-enriched-BS
AP-2rep AP-2rep
AP-3 (2) AP-3 (2)
AP-4 AP-4 TSS-enriched-BS
AR AR
uniformly-
distributed-BS
Arnt
Arnt, HIF-1, HIF-1alpha, AhR, Arnt (774 AA form),
ARNT2, AhR:Arnt, HIF-1alpha-isoform1
TSS-enriched-BS
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Representative TF TFs within the group
Binding
preference
ATF3
ATF3, ATF-4, ATF-2-xbb4, AP-1, c-Fos, c-Jun,
Fra-1, JunB, JunD, Fra-2, JunB:Fra-2, JunB:Fr a -1,
JunD:Fra-2, c-Jun:JunD, FosB, deltaFosB, ATF-1,
ATF6, ATF, CREB, deltaCREB, ATF-a, 120-kDa
CRE-binding protein, CREMalpha, ATF-2,
ATFa-isoform1, ATF5
TSS-enriched-BS
BCL-6 BCL-6
uniformly-
distributed-BS
Blimp-1 Blimp-1
uniformly-
distributed-BS
BRCA1 BRCA1, BRCA1:USF2 TSS-depleted-BS
CACCC-binding
factor
CACCC-binding factor TSS-enriched-BS
Cart-1 Cart-1 TSS-depleted-BS
CDC5L CDC5L
uniformly-
distributed-BS
CDP CDP, CDP-isoform1
uniformly-
distributed-BS
CDX2 CDX2, Cdx-1 TSS-depleted-BS
C/EBPdelta
C/EBPdelta, C/EBPgamma, C/EBPalpha,
CHOP-10, C/EBPbeta, C/EBPepsilon
TSS-depleted-BS
Chx10 Chx10
uniformly-
distributed-BS
Clock:BMAL1 Clock:BMAL1, Clock:BMAL2
c-Myb c-Myb, c-Myb-isoform1
uniformly-
distributed-BS
CP2a CP2a TSS-enriched-BS
c-Rel c-Rel
uniformly-
distributed-BS
Crx Crx, RX
uniformly-
distributed-BS
DBP DBP TSS-depleted-BS
E2F-1
E2F-1, E2F-1:DP-1, E2F:DP, E2F-2, E2F-3a, E2F-4,
E2F-5, E2F:DP:E4, DP-1, E2F-7
TSS-enriched-BS
E2F-1:DP-2 E2F-1:DP-2 TSS-enriched-BS
E2F-4:DP-1 E2F-4:DP-1
E4BP4 E4BP4
uniformly-
distributed-BS
E4F1 E4F1
uniformly-
distributed-BS
Egr-1 Egr-1, Egr-2, Egr-3, Egr-4 TSS-enriched-BS
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Representative TF TFs within the group
Binding
preference
Elk-1
Elk-1, Elk-1-isoform1, GABP-alpha:GABP-beta,
GABP-alpha, GABP-beta1, GABP-beta2, Tel-2 b,
Tel-2a, Tel-2c, c-Ets-2, PU.1, PEA3, ELF-1, c-Ets-1,
NERF-1a, Erg-1, SAP-1a, Ets-1 deltaVII, Fli-1,
ERF, NERF-1b, NERF-2, NERF-2b, Erg-2, TCF,
Spi-B, p38erg, Net, TEL1, p55, SA P-1b, p55erg,
p49erg, Tel-2d, Tel-2e, Tel-2f, ELFR, Spi-B-isoform1
TSS-enriched-BS
ERR1 ERR1
uniformly-
distributed-BS
ER-alpha ER-alpha, ER-alpha-L, ER-beta, ER-alpha:ER-beta
uniformly-
distributed-BS
ETF ETF
FAC1 FAC1, FAC1-xbb1 TSS-depleted-BS
FBI-1 FBI-1
FOXA1 FOXA1, FOXA2, FOXA3 TSS-depleted-BS
FOXC1 FOXC1
uniformly-
distributed-BS
FOXD1 FOXD1
uniformly-
distributed-BS
FOXI1 FOXI1 TSS-depleted-BS
FOXJ1a FOXJ1a, FOXJ1b, FOXD3, FOXF2, FOXF1 TSS-depleted-BS
FOXJ2 FOXJ2 TSS-depleted-BS
FOXL1 FOXL1 TSS-depleted-BS
FOXO1 FOXO1 TSS-depleted-BS
FOXO3a FOXO3a, FOXO3A-1 TSS-depleted-BS
FOXO4 FOXO4 TSS-depleted-BS
FOXN1 FOXN1
uniformly-
distributed-BS
FOXP3 FOXP3
uniformly-
distributed-BS
GATA-2
GATA-2, GATA-3 isoform-1, GATA-4, GATA-6,
GATA-1, GATA-1 isoform 1, GATA-5
TSS-depleted-BS
GCMa GCMa
uniformly-
distributed-BS
GCNF-2 GCNF-2, GCNF-1
uniformly-
distributed-BS
G1b G1b, G1
uniformly-
distributed-BS
GLI1 GLI1, GLI3, GLI2alpha
uniformly-
distributed-BS
GR-alpha GR-alpha, GR-beta, GR, PR B, PR A
uniformly-
distributed-BS
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Representative TF TFs within the group
Binding
preference
HES-1 HES-1
uniformly-
distributed-BS
HIC-1 HIC-1 TSS-enriched-BS
Hlf Hlf
uniformly-
distributed-BS
HMGI HMGI, HMG-Y, HMGI-C TSS-depleted-BS
HNF-1alpha-A
HNF-1alpha-A, HNF-1beta-A, HNF-1alpha-B,
HNF-1alpha-C, HNF-1beta-B, HNF-1beta-C
TSS-depleted-BS
HOXA4 HOXA4
HOXA7 HOXA7
HOXA9B HOXA9B, Meis-1
uniformly-
distributed-BS
HSF HSF
uniformly-
distributed-BS
HSF1-L HSF1-L, HSF1-S
uniformly-
distributed-BS
HSF2 HSF2, HSF2A
uniformly-
distributed-BS
Ikaros Ikaros
IPF1 IPF1, IPF1:Pbx
uniformly-
distributed-BS
IRF-7A
IRF-7A, IRF-1, IRF-8, IRF-2, IRF-3, IRF-4, IRF-5,
IRF-7H, IRF-6, ISGF-3, IRF-9
TSS-depleted-BS
Kid3 Kid3
LBP-1 LBP-1
LEF-1
LEF-1, TCF-1, TCF-1A, TCF-1B, TCF-1C,
TCF-1E, TCF-1F, TCF-1G
uniformly-
distributed-BS
LF-A1 LF-A1
LHX3a LHX3a, LHX3b TSS-depleted-BS
Lmo2 Lmo2
uniformly-
distributed-BS
LRH-1 LRH-1, LRH-1-xbb1, LRH-1-isoform1
uniformly-
distributed-BS
MAZR MAZR TSS-enriched-BS
MAZ MAZ TSS-enriched-BS
MIF-1 MIF-1 TSS-enriched-BS
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Representative TF TFs within the group
Binding
preference
MRF-2-isoform1
MRF-2-isoform1, USF2, USF2a, MyoD, Tal1-PP42,
E12, E47, TFE3, TFEB-isoform1, MITF, MITF-M1 ,
DEC1, DEC2, HTF4, HTF4gamma, ITF-2,
Tal1-PP22, SEF2-1B, ITF, ITF-1, Myogenin, Myf-5,
Myf-6, MASH-1, INSAF, c-Myc, Max-isoform2,
Max-isoform1, Max, USF1, USF2b, Mxi1, Mad1,
deltaMax, Tal-2, HEN1, HEB1-p94, HEB1-p67,
N-Myc, HAND1, HAND2, USF1:USF2
MTF-1 MTF-1 TSS-enriched-BS
MZF1B-C MZF1B-C TSS-enriched-BS
NCX NCX
uniformly-
distributed-BS
NF-1 NF-1, CTF, CTF-1, CTF-2
uniformly-
distributed-BS
NF-AT1 NF-AT1, NF-AT2, NF-AT4, NF-AT3, NF-AT1C TSS-depleted-BS
NF-muE1 NF-muE1
uniformly-
distributed-BS
NF-Y NF-Y, NF-YB, NF-YA, NF-YC-3, NF-YA-L TSS-enriched-BS
Nkx2-1 Nkx2-1, Nkx2-1-isoform1
uniformly-
distributed-BS
Nkx2-2 Nkx2-2
uniformly-
distributed-BS
Nkx2-5 Nkx2-5
uniformly-
distributed-BS
Nkx3-1 Nkx3-1, Nkx3-1 v1, Nkx3-1 v2, Nkx3-1 v3, Nkx3-1 v4 TSS-depleted-BS
Nkx6-1 Nkx6-1 TSS-depleted-BS
Nkx6-2 Nkx6-2 TSS-depleted-BS
NRF-1 NRF-1 TSS-enriched-BS
Nrf2
Nrf2, Nrf2-isoform1, LCR-F1, Bach1, NF-E2, NF-E2,
p45, Bach2, Nrf1, MafG, MafK, Nrf1:MafK,
Nrf2:MafK, Nrf3:MafK, MafG:MafG, Nrf1:MafG,
Nrf2:MafG, MafF, MafB, Maf
uniformly-
distributed-BS
OC-2 OC-2, HNF-6alpha TSS-depleted-BS
Otx1 Otx1, Otx2
uniformly-
distributed-BS
p300 p300 TSS-enriched-BS
p53
p53, p53-isoform1, p73alpha, DeltaNp63alpha,
p63gamma, p73beta
uniformly-
distributed-BS
Pax-1 Pax-1
uniformly-
distributed-BS
Pax-5 Pax-5, Pax-8, Pax-2
uniformly-
distributed-BS
Pax-3 Pax-3
uniformly-
distributed-BS
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Representative TF TFs within the group
Binding
preference
Pax-6 Pax-6, Pax-6 / Pd-5a
uniformly-
distributed-BS
Pbx1a
Pbx1a, Pbx1b, Pbx2, Pbx3a, Pbx3b, Pbx1:Prep1,
Pbx1:HOXB1, Pbx, Pbx1b:Prep1, Pbx2:Prep1, Pb
x1a:HOXC6, Pbx2:HOXC6, Pbx3a:HOXC6,
Pbx1a:HOXB7, Pbx1a:HOXB8, Pbx1a:IPF1
uniformly-
distributed-BS
Pbx1 Pbx1
uniformly-
distributed-BS
Pit-1B Pit-1B TSS-depleted-BS
PITX2 PITX2, PITX2A TSS-depleted-BS
PLZF PLZF, PLZFB TSS-depleted-BS
POU3F1
POU3F1, POU3F2, POU3F2 (N-Oct-5a), POU3F2
(N-Oct-5b), POU2F1, Oct-1, POU2F2 (Oct-2.1),
Oct-2, POU2F2B, oct-B2, oct-B3, Oct-2.1,
POU5F1A, Octa-factor, octamer-bindin g factor,
POU5F1B, OCA-B, POU4F1(l), POU5F1C
TSS-depleted-BS
PPARgamma1
PPARgamma1, PPARgamma2, VDR, CAR,
PXR-1A, FXR, FXR:RXR-alpha,
LXR-alpha:RXR-alpha, LXR-b eta:RXR-alpha,
HNF-4alpha2, RAR-alpha1, RAR-gamma,
RAR-beta, T3R-alpha, T3R-beta1, T3R-alpha1,
T3R-alpha2, RAR-beta2, RXR-beta, RXR-alpha,
RXR-gamma, RAR-alpha, RAR-alpha:RXR -alpha,
RAR-alpha:RXR-gamma, COUP-TF2, COUP-TF1,
HNF-4gamma, HNF-4, HNF-4alpha,
PPARalpha:RXR-alpha, LXR-alpha, LXR-beta,
SXR:RXR-alpha, PXR-1A:RXR-alpha,
PXR-1A:RXR-beta, C AR:RXR-alpha,
HNF-4alpha1, HNF-4alpha4, HNF-4alpha3,
HNF-4alpha7, PPARalpha, FXR-alpha
uniformly-
distributed-BS
PR PR
uniformly-
distributed-BS
pRb:E2F-1:DP-1 pRb:E2F-1:DP-1
PXR:RXR-alpha PXR:RXR-alpha
RBP-Jkappa RBP-Jkappa
uniformly-
distributed-BS
RelA-p65
RelA-p65, p50, NF-kappaB, p52, NF-kappaB(-like),
NF-kappaB1, p100, NF-kappaB2 (p49)
uniformly-
distributed-BS
REST-form2 REST-form2, REST-form1, REST TSS-enriched-BS
RFX2
RFX2, RFX3, RFX5, RFX1, RFX4, RFX1:RFX2,
RFX1:RFX3, RFXANK, RFXAP,
RFX5:RFXAP:RFXANK
uniformly-
distributed-BS
RORalpha1 RORalpha1, RORalpha2, RORalpha3, RORalpha
uniformly-
distributed-BS
RP58 RP58
uniformly-
distributed-BS
RREB-1 RREB-1 TSS-enriched-BS
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Representative TF TFs within the group
Binding
preference
RSRFC4 RSRFC4 TSS-depleted-BS
SF-1 SF-1
uniformly-
distributed-BS
Smad3
Smad3, Smad4, Smad1, Smad2-L, Smad3:Smad4,
Smad7, Smad6, Smad5, Smad2 (437 AA),
Smad4delta3, Smad4delta6, Smad4delta5-6,
Smad4delta4-6, Smad4delta4-7
uniformly-
distributed-BS
Sp1 Sp1, Sp3-isoform1, Sp2, Sp3, Sp4 TSS-enriched-BS
SREBP-2
SREBP-2, SREBP-1a, SREBP-1b, SREBP-1c,
SREBP-1
uniformly-
distributed-BS
SRF SRF
uniformly-
distributed-BS
SRY
SRY, Sox4, Sox9, Sox5, Sox11, Sox12, Sox20, Sox2,
Sox3, Sox8, Sox10, Sox14, Sox18, Sox21
uniformly-
distributed-BS
STAT5B
STAT5B, STAT6, STAT1alpha, STAT1beta, STAT1,
STAT3, STAT5A, STAT4, STAT2
uniformly-
distributed-BS
SZF1-1 SZF1-1
uniformly-
distributed-BS
TBP TBP, TFIID TSS-enriched-BS
TBX5-L TBX5-L TSS-depleted-BS
TCF-4 TCF-4
TEF-1 TEF-1 TSS-depleted-BS
TEF-xbb1 TEF-xbb1 TSS-depleted-BS
TFIIA
TFIIA, TFIIA-alpha/beta precursor (major),
TFIIA-alpha/beta precursor (minor), TFIIA-gamma
TSS-enriched-BS
TFII-I TFII-I TSS-enriched-BS
TGIF TGIF, TGIF-isoform2
uniformly-
distributed-BS
Topors-isoform1 Topors-isoform1 TSS-depleted-BS
WT1
WT1, WT1 I -KTS, WT1 -KTS, WT1 I, WT1-del2,
WT1 I-del2
XBP-1 XBP-1
uniformly-
distributed-BS
YY1 YY1 TSS-enriched-BS
ZBRK1 ZBRK1
uniformly-
distributed-BS
ZBTB7B ZBTB7B
uniformly-
distributed-BS
ZEB (1124 AA) ZEB (1124 AA)
uniformly-
distributed-BS
ZIC2 ZIC2
uniformly-
distributed-BS
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Representative TF TFs within the group
Binding
preference
ZID ZID
uniformly-
distributed-BS
ZNF219 ZNF219 TSS-enriched-BS
Appendix B
Identication of novel putative
SREBP target genes
Table B.1. Dierentially regulated genes in broblasts and HeLa
cells under sterol-depletion.
A Genes up-regulated under sterol-depleted conditions
Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
HMGCR
3-hydroxy-3-methylglutaryl-CoA
reductase
3.5239 0 4.3366 0
FADS1 fatty acid desaturase 1 3.1754 0 1.9445 0.0012
INSIG1 insulin induced gene 1 2.8316 0.0019 3.2167 0
RGS2
regulator of G-protein signaling 2,
24kDa
2.4397 0.0021 1.6181 0.0281
IDI1
isopentenyl-diphosphate delta
isomerase 1
2.2995 0.0028 2.1098 0.0013
SCD
stearoyl-CoA desaturase
(delta-9-desaturase)
2.1175 0.0038 1.9835 0.0011
LPIN1 lipin 1 2.0214 0.004 1.7186 0.049
DHCR7 7-dehydrocholesterol reductase 1.9957 0.0043 1.883 0.0034
ACSS2
acyl-CoA synthetase short-chain
family member 2
2.1836 0.0044 5.5355 0
TRIB3 tribbles homolog 3 (Drosophila) 1.4702 0.0089 1.6387 0.0434
ACLY ATP citrate lyase 1.9234 0.0095 1.6379 0.0178
TMEM55B transmembrane protein 55B 1.7783 0.0133 2.0197 0.0017
SQLE squalene epoxidase 1.7449 0.0157 2.4489 0
FASN fatty acid synthase 1.7046 0.0185 1.8882 1.00E-04
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
ACAT2 acetyl-CoA acetyltransferase 2 1.6689 0.0358 1.9446 9.00E-04
SC4MOL sterol-C4-methyl oxidase-like 1.5652 0.0468 3.7526 0
HES6
hairy and enhancer of split 6
(Drosophila)
3.7806 0
BHLHE40
basic helix-loop-helix family, member
e40
2.616 3.00E-04
RGS16 regulator of G-protein signaling 16 2.9205 4.00E-04
HMGCS1
3-hydroxy-3-methylglutaryl-CoA
synthase 1 (soluble)
3.1076 5.00E-04
TMEM97 transmembrane protein 97 2.6274 0.0014
MVD
mevalonate (diphospho)
decarboxylase
2.3226 0.0023
MAFB
v-maf musculoaponeurotic
brosarcoma oncogene homolog B
(avian)
2.3337 0.0024
STC1 stanniocalcin 1 2.3742 0.0028
FABP3
fatty acid binding protein 3, muscle
and heart (mammary-derived growth
inhibitor)
2.3738 0.003
KLF6 Kruppel-like factor 6 3.1659 0.0031
PIK3IP1
phosphoinositide-3-kinase interacting
protein 1
2.3102 0.0031
PDGFRB
platelet-derived growth factor
receptor, beta polypeptide
2.3345 0.0035
TM7SF2
transmembrane 7 superfamily
member 2
2.155 0.0036
SLC20A1
solute carrier family 20 (phosphate
transporter), member 1
2.0112 0.004
PFKFB4
6-phosphofructo-2-kinase/fructose-
2,6-biphosphatase
4
2.0521 0.004
KIAA1199 KIAA1199 2.4186 0.0041
RGS4 regulator of G-protein signaling 4 2.2216 0.0043
PDGFRL
platelet-derived growth factor
receptor-like
2.2106 0.0043
C17orf59 chromosome 17 open reading frame 59 2.0269 0.0045
PCDH18 protocadherin 18 2.1986 0.0066
MXRA5 matrix-remodelling associated 5 2.1595 0.0086
LDLR low density lipoprotein receptor 1.8743 0.0089
GAS1 growth arrest-specic 1 2.0526 0.0096
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
TP53INP2
tumor protein p53 inducible nuclear
protein 2
1.8091 0.0101
KLF9 Kruppel-like factor 9 1.7681 0.0117
DBC1 deleted in bladder cancer 1 1.906 0.0128
SLC2A6
solute carrier family 2 (facilitated
glucose transporter), member 6
1.8013 0.0132
TP53INP1
tumor protein p53 inducible nuclear
protein 1
1.7629 0.015
KCNJ2
potassium inwardly-rectifying
channel, subfamily J, member 2
1.8601 0.0151
ANGPTL2 angiopoietin-like 2 1.7884 0.0151
BCL10 B-cell CLL/lymphoma 10 1.7948 0.0154
PDGFRA
platelet-derived growth factor
receptor, alpha polypeptide
1.8534 0.0155
HSD17B12
hydroxysteroid (17-beta)
dehydrogenase 12
1.7475 0.0155
FBLN1 bulin 1 2.4985 0.0167
SH3PXD2B SH3 and PX domains 2B 1.6868 0.0172
C3orf54 chromosome 3 open reading frame 54 1.7694 0.0175
KLF13 Kruppel-like factor 13 1.669 0.0183
MNT MAX binding protein 1.678 0.0185
ELOVL5
ELOVL family member 5, elongation
of long chain fatty acids (FEN1/Elo2,
SUR4/Elo3-like, yeast)
1.6902 0.0209
TOB1 transducer of ERBB2, 1 1.7352 0.0218
MYO1D myosin ID 1.7072 0.0224
ELOVL6
ELOVL family member 6, elongation
of long chain fatty acids (FEN1/Elo2,
SUR4/Elo3-like, yeast)
1.6842 0.0306
INO80C INO80 complex subunit C 1.6071 0.0309
DNAJB9
DnaJ (Hsp40) homolog, subfamily B,
member 9
1.6304 0.0309
C13orf15 chromosome 13 open reading frame 15 1.9172 0.0323
C10orf58 chromosome 10 open reading frame 58 1.5965 0.0328
SELS selenoprotein S 2.3198 0.0329
MFAP4 microbrillar-associated protein 4 1.9284 0.033
ZCCHC14
zinc nger, CCHC domain containing
14
1.6118 0.0349
CKS2
CDC28 protein kinase regulatory
subunit 2
1.7607 0.0351
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
MYO10 myosin X 1.5884 0.0377
PTGS2
prostaglandin-endoperoxide synthase
2 (prostaglandin G/H synthase and
cyclooxygenase)
1.5625 0.038
SLIT3 slit homolog 3 (Drosophila) 1.6017 0.038
SAT1
spermidine/spermine
N1-acetyltransferase 1
1.4897 0.0381
FRMD8 FERM domain containing 8 1.6735 0.0392
HIST2H2BE histone cluster 2, H2be 1.5447 0.0393
SLC26A6 solute carrier family 26, member 6 1.5668 0.0415
ZC3H12A
zinc nger CCCH-type containing
12A
1.5342 0.0415
ITGA11 integrin, alpha 11 1.6568 0.0417
IER5L immediate early response 5-like 1.5482 0.0419
AKR1C3
aldo-keto reductase family 1, member
C3 (3-alpha hydroxysteroid
dehydrogenase, type II)
1.8076 0.0437
RNF150 ring nger protein 150 1.6551 0.0438
DDIT4 DNA-damage-inducible transcript 4 1.1515 0.0444
HCFC1R1
host cell factor C1 regulator 1 (XPO1
dependent)
1.5468 0.0458
GP1BB
glycoprotein Ib (platelet), beta
polypeptide
1.5687 0.0462
IL8 interleukin 8 1.0995 0.047
NMB neuromedin B 1.5495 0.0473
SNAI1 snail homolog 1 (Drosophila) 1.5163 0.0474
FBXO32 F-box protein 32 1.1042 0.0484
MSX1 msh homeobox 1 1.4492 0.0485
CXXC5 CXXC nger protein 5 1.5027 0.0495
CPSF1
cleavage and polyadenylation specic
factor 1, 160kDa
2.5922 0
CYP51A1
cytochrome P450, family 51,
subfamily A, polypeptide 1
2.3338 1.00E-04
CCNG2 cyclin G2 2.3832 1.00E-04
NFE2
nuclear factor (erythroid-derived 2),
45kDa
2.0575 3.00E-04
TMLHE trimethyllysine hydroxylase, epsilon 2.1874 3.00E-04
NSDHL
NAD(P) dependent steroid
dehydrogenase-like
2.038 3.00E-04
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
SLCO2A1
solute carrier organic anion
transporter family, member 2A1
2.1154 3.00E-04
FLVCR1
feline leukemia virus subgroup C
cellular receptor 1
2.0854 7.00E-04
HSD17B7
hydroxysteroid (17-beta)
dehydrogenase 7
1.9727 0.0018
FDFT1
farnesyl-diphosphate
farnesyltransferase 1
1.8615 0.0072
TCP1 t-complex 1 1.6476 0.0077
EPDR1
ependymin related protein 1
(zebrash)
1.6476 0.0077
SNORA29 small nucleolar RNA, H/ACA box 29 1.6476 0.0077
GMNN geminin, DNA replication inhibitor 1.0727 0.0079
C20orf20 chromosome 20 open reading frame 20 1.0461 0.0095
RASD1 RAS, dexamethasone-induced 1 1.0021 0.0117
PCYT2
phosphate cytidylyltransferase 2,
ethanolamine
1.1331 0.017
CDC16
cell division cycle 16 homolog (S.
cerevisiae)
1.0945 0.0264
EPR1
eector cell peptidase receptor 1
(non-protein coding)
1.0634 0.0275
BIRC5 baculoviral IAP repeat-containing 5 1.0634 0.0275
FAM166B
family with sequence similarity 166,
member B
1.073 0.0286
FADS2 fatty acid desaturase 2 1.6762 0.0302
FGFBP1
broblast growth factor binding
protein 1
1.6993 0.0318
RORB RAR-related orphan receptor B 1.6022 0.0325
RNF216L ring nger protein 216-like 1.0568 0.0333
FAM189B
family with sequence similarity 189,
member B
1.6427 0.0364
MVK mevalonate kinase 1.6572 0.0399
SLC2A3P1
solute carrier family 2 (facilitated
glucose transporter), member 3
pseudogene 1
1.6067 0.0426
STARD4
StAR-related lipid transfer (START)
domain containing 4
1.5488 0.0456
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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B Genes down-regulated under sterol-depleted conditions
Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
ID2
inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
0.4843 0.0142 0.463 0
CDC42EP3
CDC42 eector protein (Rho GTPase
binding) 3
0.614 0.0303 0.5798 0.0457
CDC20
cell division cycle 20 homolog (S.
cerevisiae)
0.3398 0
ACTC1 actin, alpha, cardiac muscle 1 0.4843 0.0167
F3
coagulation factor III
(thromboplastin, tissue factor)
0.4966 0.0192
SPOCD1 SPOC domain containing 1 0.4696 0.0194
TUFT1 tuftelin 1 0.5733 0.0202
S100P S100 calcium binding protein P 0.4455 0.0207
CRIP1 cysteine-rich protein 1 (intestinal) 0.5225 0.0208
TSC22D2 TSC22 domain family, member 2 0.5632 0.0209
KRTAP1-5 keratin associated protein 1-5 0.5769 0.0212
NUSAP1
nucleolar and spindle associated
protein 1
0.5579 0.0215
KRTAP1-1 keratin associated protein 1-1 0.5745 0.0217
NTF3 neurotrophin 3 0.5795 0.0218
GLIPR1 GLI pathogenesis-related 1 0.5703 0.0218
GAGE5 G antigen 5 0.5047 0.0221
PBK PDZ binding kinase 0.5954 0.0224
CCNB2 cyclin B2 0.5427 0.0226
TRIP13
thyroid hormone receptor interactor
13
0.5103 0.0226
KLF2 Kruppel-like factor 2 (lung) 0.5312 0.0228
PTTG1 pituitary tumor-transforming 1 0.5504 0.0229
KIF20A kinesin family member 20A 0.5582 0.0233
LCE2B late cornied envelope 2B 0.5145 0.0233
IQGAP3
IQ motif containing GTPase
activating protein 3
0.531 0.0236
CENPF
centromere protein F, 350/400kDa
(mitosin)
0.5962 0.0238
AXL AXL receptor tyrosine kinase 0.5541 0.0239
TOP2A
topoisomerase (DNA) II alpha
170kDa
0.4787 0.024
PRC1 protein regulator of cytokinesis 1 0.5529 0.0242
GAGE4 G antigen 4 0.5159 0.0244
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
TPM1 tropomyosin 1 (alpha) 0.4236 0.0251
PMP22 peripheral myelin protein 22 0.4008 0.0274
NGF
nerve growth factor (beta
polypeptide)
0.5006 0.0293
LCE3A late cornied envelope 3A 0.586 0.0304
GAGE2C G antigen 2C 0.5241 0.0312
KPRP keratinocyte proline-rich protein 0.5925 0.0317
GAGE2E G antigen 2E 0.5355 0.0328
ASPM
asp (abnormal spindle) homolog,
microcephaly associated (Drosophila)
0.6177 0.0329
COL4A1 collagen, type IV, alpha 1 0.6171 0.0332
CEP55 centrosomal protein 55kDa 0.6256 0.0334
OXTR oxytocin receptor 0.6168 0.0336
DUSP1 dual specicity phosphatase 1 0.5624 0.0336
TIPARP
TCDD-inducible poly(ADP-ribose)
polymerase
0.5414 0.034
TK1 thymidine kinase 1, soluble 0.626 0.0341
CA12 carbonic anhydrase XII 0.6156 0.0345
GAGE12I G antigen 12I 0.5524 0.0381
CPS1
carbamoyl-phosphate synthase 1,
mitochondrial
0.5324 0.0397
GAGE6 G antigen 6 0.527 0.04
IL12A
interleukin 12A (natural killer cell
stimulatory factor 1, cytotoxic
lymphocyte maturation factor 1, p35)
0.5829 0.0402
PTX3 pentraxin 3, long 0.5853 0.0408
HIST1H4C histone cluster 1, H4c 0.5847 0.0421
RPL29 ribosomal protein L29 0.6387 0.0428
SKP2
S-phase kinase-associated protein 2
(p45)
0.5616 0.0443
HERC5 hect domain and RLD 5 0.5758 0.0457
GADD45B
growth arrest and
DNA-damage-inducible, beta
0.6555 0.0465
C4BPA
complement component 4 binding
protein, alpha
0.5507 0.0468
DTL denticleless homolog (Drosophila) 0.659 0.0499
ID1
inhibitor of DNA binding 1, dominant
negative helix-loop-helix protein
0.4106 0
LOC285556 hypothetical protein LOC285556 0.6027 0
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
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Fibroblasts HeLa cells
Symbol Name FC1 pfp2 FC1 pfp2
MCM5
minichromosome maintenance
complex component 5
0.9409 3.00E-04
GBP1
guanylate binding protein 1,
interferon-inducible, 67kDa
0.4885 4.00E-04
PTGES3 prostaglandin E synthase 3 (cytosolic) 0.9244 5.00E-04
LIMA1 LIM domain and actin binding 1 0.556 0.0023
IL7R interleukin 7 receptor 0.5309 0.0062
CXCR2 chemokine (C-X-C motif) receptor 2 0.6894 0.0117
MORC4 MORC family CW-type zinc nger 4 0.8871 0.0127
MYPN myopalladin 0.5818 0.0132
C6orf146 chromosome 6 open reading frame 146 0.9768 0.0146
MAML2 mastermind-like 2 (Drosophila) 0.5794 0.0157
EDN2 endothelin 2 0.5874 0.0195
GBP3 guanylate binding protein 3 0.5946 0.0276
UBXN1 UBX domain protein 1 0.7756 0.0442
ARHGEF12
Rho guanine nucleotide exchange
factor (GEF) 12
0.8545 0.0445
MRPS33 mitochondrial ribosomal protein S33 0.9823 0.0454
1 Fold change in broblasts or HeLa-cells
2 Percentage of false positives (false discovery rate) in broblasts or HeLa-cells
Table B.3. Comparison of /textitin silico predicted SREBP and
NF-Y target genes with identied target genes from ENCODE [65]
project.
SREBP NF-Y
Symbol Gene Name Predicted* ENCODE* Predicted* ENCODE*
HES6
hairy and enhancer of split 6
(Drosophila)
x x x x
CPSF1
cleavage and polyadenylation
specic factor 1, 160kDa
x x x
CCNG2 cyclin G2 x x x x
SLCO2A1
solute carrier organic anion
transporter family, member 2A1
x
BHLHE40
basic helix-loop-helix family,
member e40
x x x
FLVCR1
feline leukemia virus subgroup C
cellular receptor 1
x x x x
TMEM97 transmembrane protein 97 x x x
* x in columns 3 and 5 indicates predicted binding sites for SREBP and NF-Y and identied binding
sites for SREBP and NF-Y from ENCODE in columns 4 and 6.
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SREBP NF-Y
Symbol Gene Name Predicted* ENCODE* Predicted* ENCODE*
HSD17B7
hydroxysteroid (17-beta)
dehydrogenase 7
x x x
INSIG1 insulin induced gene 1 x x x
MVD
mevalonate (diphospho)
decarboxylase
x x x x
MAFB
v-maf musculoaponeurotic
brosarcoma oncogene homolog
B (avian)
x x
STC1 stanniocalcin 1 x x x
IDI1
isopentenyl-diphosphate delta
isomerase 1
x x x x
FABP3
fatty acid binding protein 3,
muscle and heart
(mammary-derived growth
inhibitor)
x x
KLF6 Kruppel-like factor 6 x x x x
PDGFRB
platelet-derived growth factor
receptor, beta polypeptide
x x x
SCD
stearoyl-CoA desaturase
(delta-9-desaturase)
x x x
LPIN1 lipin 1 x x x x
PFKFB4
6-phosphofructo-2-
kinase/fructose-2,6-
biphosphatase
4
x
DHCR7 7-dehydrocholesterol reductase x x x x
RGS4 regulator of G-protein signaling 4 x x
C17orf59
chromosome 17 open reading
frame 59
x x x
FDFT1
farnesyl-diphosphate
farnesyltransferase 1
x x x x
MXRA5 matrix-remodelling associated 5 x
LDLR low density lipoprotein receptor x x x
C20orf20
chromosome 20 open reading
frame 20
x x
GAS1 growth arrest-specic 1 x
TP53INP2
tumor protein p53 inducible
nuclear protein 2
x x x x
RASD1 RAS, dexamethasone-induced 1 x
DBC1 deleted in bladder cancer 1 x
SLC2A6
solute carrier family 2 (facilitated
glucose transporter), member 6
x x
* x in columns 3 and 5 indicates predicted binding sites for SREBP and NF-Y and identied binding
sites for SREBP and NF-Y from ENCODE in columns 4 and 6.
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SREBP NF-Y
Symbol Gene Name Predicted* ENCODE* Predicted* ENCODE*
TMEM55B transmembrane protein 55B x x x x
TP53INP1
tumor protein p53 inducible
nuclear protein 1
x x x x
KCNJ2
potassium inwardly-rectifying
channel, subfamily J, member 2
x x x
ANGPTL2 angiopoietin-like 2 x x
HSD17B12
hydroxysteroid (17-beta)
dehydrogenase 12
x x x x
PDGFRA
platelet-derived growth factor
receptor, alpha polypeptide
x
SQLE squalene epoxidase x x x x
FBLN1 bulin 1 x
PCYT2
phosphate cytidylyltransferase 2,
ethanolamine
x x
C3orf54
chromosome 3 open reading
frame 54
x x
KLF13 Kruppel-like factor 13 x x
FASN fatty acid synthase x x x
MNT MAX binding protein x x x
TOB1 transducer of ERBB2, 1 x x x x
MYO1D myosin ID x
EPR1
eector cell peptidase receptor 1
(non-protein coding)
x
BIRC5
baculoviral IAP
repeat-containing 5
x x
ELOVL6
ELOVL family member 6,
elongation of long chain fatty
acids (FEN1/Elo2,
SUR4/Elo3-like, yeast)
x
DNAJB9
DnaJ (Hsp40) homolog,
subfamily B, member 9
x x
RORB RAR-related orphan receptor B x x
ZCCHC14
zinc nger, CCHC domain
containing 14
x x x
FAM189B
family with sequence similarity
189, member B
x x x
MYO10 myosin X x
SLIT3 slit homolog 3 (Drosophila) x x x
SAT1
spermidine/spermine
N1-acetyltransferase 1
x x x
FRMD8 FERM domain containing 8 x x x x
* x in columns 3 and 5 indicates predicted binding sites for SREBP and NF-Y and identied binding
sites for SREBP and NF-Y from ENCODE in columns 4 and 6.
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SREBP NF-Y
Symbol Gene Name Predicted* ENCODE* Predicted* ENCODE*
MVK mevalonate kinase x x x x
ZC3H12A
zinc nger CCCH-type
containing 12A
x x
SLC26A6
solute carrier family 26, member
6
x x x x
IER5L immediate early response 5-like x x x
SLC2A3P1
solute carrier family 2 (facilitated
glucose transporter), member 3
pseudogene 1
x
DDIT4
DNA-damage-inducible
transcript 4
x x x
HCFC1R1
host cell factor C1 regulator 1
(XPO1 dependent)
x x
GP1BB
glycoprotein Ib (platelet), beta
polypeptide
x x x
SNAI1 snail homolog 1 (Drosophila) x x x
MSX1 msh homeobox 1 x x x
CXXC5 CXXC nger protein 5 x x
CDC20
cell division cycle 20 homolog (S.
cerevisiae)
x x
LOC285556 hypothetical protein LOC285556 x
PTGES3
prostaglandin E synthase 3
(cytosolic)
x
CXCR2
chemokine (C-X-C motif)
receptor 2
x x x
ID2
inhibitor of DNA binding 2,
dominant negative
helix-loop-helix protein
x x x
MAML2 mastermind-like 2 (Drosophila) x
ACTC1 actin, alpha, cardiac muscle 1 x
F3
coagulation factor III
(thromboplastin, tissue factor)
x x
SPOCD1 SPOC domain containing 1 x
EDN2 endothelin 2 x
S100P S100 calcium binding protein P x
CRIP1
cysteine-rich protein 1
(intestinal)
x
TSC22D2 TSC22 domain family, member 2 x x
NTF3 neurotrophin 3 x
TRIP13
thyroid hormone receptor
interactor 13
x x x
* x in columns 3 and 5 indicates predicted binding sites for SREBP and NF-Y and identied binding
sites for SREBP and NF-Y from ENCODE in columns 4 and 6.
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SREBP NF-Y
Symbol Gene Name Predicted* ENCODE* Predicted* ENCODE*
KLF2 Kruppel-like factor 2 (lung) x
IQGAP3
IQ motif containing GTPase
activating protein 3
x
AXL AXL receptor tyrosine kinase x x
PRC1 protein regulator of cytokinesis 1 x x x
PMP22 peripheral myelin protein 22 x x
GBP3 guanylate binding protein 3 x x
CDC42EP3
CDC42 eector protein (Rho
GTPase binding) 3
x
ASPM
asp (abnormal spindle) homolog,
microcephaly associated
(Drosophila)
x x x
CEP55 centrosomal protein 55kDa x x x
DUSP1 dual specicity phosphatase 1 x x
OXTR oxytocin receptor x
TIPARP
TCDD-inducible
poly(ADP-ribose) polymerase
x x
CA12 carbonic anhydrase XII x x x
RPL29 ribosomal protein L29 x
UBXN1 UBX domain protein 1 x
GADD45B
growth arrest and
DNA-damage-inducible, beta
x x x
* x in columns 3 and 5 indicates predicted binding sites for SREBP and NF-Y and identied binding
sites for SREBP and NF-Y from ENCODE in columns 4 and 6.
Table B.4. Conservation of predicted SREBP binding sites in chimp
and mouse.
Symbol Gene Name Predicted* Chimp* Mouse*
HES6 hairy and enhancer of split 6 (Drosophila) x x x
CPSF1
cleavage and polyadenylation specic factor
1, 160kDa
x x x
CCNG2 cyclin G2 x x
SLCO2A1
solute carrier organic anion transporter
family, member 2A1
x x x
BHLHE40 basic helix-loop-helix family, member e40 x x x
FLVCR1
feline leukemia virus subgroup C cellular
receptor 1
x
TMEM97 transmembrane protein 97 x x x
* x in column 3 indicates predicted binding sites for SREBP in human and in columns 4 and 5 conserved
predicted SREBP binding sites in chimp and mouse, respectively.
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Symbol Gene Name Predicted* Chimp* Mouse*
HSD17B7 hydroxysteroid (17-beta) dehydrogenase 7 x x x
INSIG1 insulin induced gene 1 x x x
MVD mevalonate (diphospho) decarboxylase x x
MAFB
v-maf musculoaponeurotic brosarcoma
oncogene homolog B (avian)
x x x
STC1 stanniocalcin 1 x x x
IDI1 isopentenyl-diphosphate delta isomerase 1 x x
FABP3
fatty acid binding protein 3, muscle and heart
(mammary-derived growth inhibitor)
x x x
KLF6 Kruppel-like factor 6 x x
PDGFRB
platelet-derived growth factor receptor, beta
polypeptide
x x x
SCD stearoyl-CoA desaturase (delta-9-desaturase) x x x
LPIN1 lipin 1 x x x
PFKFB4
6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase
4
x x x
DHCR7 7-dehydrocholesterol reductase x x
RGS4 regulator of G-protein signaling 4 x x x
C17orf59 chromosome 17 open reading frame 59 x x
FDFT1 farnesyl-diphosphate farnesyltransferase 1 x x
MXRA5 matrix-remodelling associated 5 x x
LDLR low density lipoprotein receptor x x x
C20orf20 chromosome 20 open reading frame 20 x x x
GAS1 growth arrest-specic 1 x x
TP53INP2 tumor protein p53 inducible nuclear protein 2 x x x
RASD1 RAS, dexamethasone-induced 1 x x x
DBC1 deleted in bladder cancer 1 x x x
SLC2A6
solute carrier family 2 (facilitated glucose
transporter), member 6
x x x
TMEM55B transmembrane protein 55B x x
TP53INP1 tumor protein p53 inducible nuclear protein 1 x x x
KCNJ2
potassium inwardly-rectifying channel,
subfamily J, member 2
x
ANGPTL2 angiopoietin-like 2 x x
HSD17B12 hydroxysteroid (17-beta) dehydrogenase 12 x x x
PDGFRA
platelet-derived growth factor receptor, alpha
polypeptide
x x x
* x in column 3 indicates predicted binding sites for SREBP in human and in columns 4 and 5 conserved
predicted SREBP binding sites in chimp and mouse, respectively.
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Symbol Gene Name Predicted* Chimp* Mouse*
SQLE squalene epoxidase x x
FBLN1 bulin 1 x x
PCYT2
phosphate cytidylyltransferase 2,
ethanolamine
x x x
C3orf54 chromosome 3 open reading frame 54 x x x
KLF13 Kruppel-like factor 13 x x x
FASN fatty acid synthase x x x
MNT MAX binding protein x x x
TOB1 transducer of ERBB2, 1 x x x
MYO1D myosin ID x x
EPR1
eector cell peptidase receptor 1 (non-protein
coding)
x x
BIRC5 baculoviral IAP repeat-containing 5 x x x
ELOVL6
ELOVL family member 6, elongation of long
chain fatty acids (FEN1/Elo2,
SUR4/Elo3-like, yeast)
x x x
DNAJB9
DnaJ (Hsp40) homolog, subfamily B, member
9
x x x
RORB RAR-related orphan receptor B x x x
ZCCHC14 zinc nger, CCHC domain containing 14 x x x
FAM189B
family with sequence similarity 189, member
B
x x x
MYO10 myosin X x
SLIT3 slit homolog 3 (Drosophila) x x
SAT1 spermidine/spermine N1-acetyltransferase 1 x x x
FRMD8 FERM domain containing 8 x x x
MVK mevalonate kinase x x x
ZC3H12A zinc nger CCCH-type containing 12A x x x
SLC26A6 solute carrier family 26, member 6 x x x
IER5L immediate early response 5-like x x x
SLC2A3P1
solute carrier family 2 (facilitated glucose
transporter), member 3 pseudogene 1
x x
DDIT4 DNA-damage-inducible transcript 4 x x x
HCFC1R1
host cell factor C1 regulator 1 (XPO1
dependent)
x x x
GP1BB glycoprotein Ib (platelet), beta polypeptide x x x
SNAI1 snail homolog 1 (Drosophila) x x x
MSX1 msh homeobox 1 x x x
* x in column 3 indicates predicted binding sites for SREBP in human and in columns 4 and 5 conserved
predicted SREBP binding sites in chimp and mouse, respectively.
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Symbol Gene Name Predicted* Chimp* Mouse*
CXXC5 CXXC nger protein 5 x x x
CDC20 cell division cycle 20 homolog (S. cerevisiae) x x x
LOC285556 hypothetical protein LOC285556 x x x
PTGES3 prostaglandin E synthase 3 (cytosolic) x x
CXCR2 chemokine (C-X-C motif) receptor 2 x x
ID2
inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
x x x
MAML2 mastermind-like 2 (Drosophila) x x
ACTC1 actin, alpha, cardiac muscle 1 x x x
F3
coagulation factor III (thromboplastin, tissue
factor)
x x x
SPOCD1 SPOC domain containing 1 x x
EDN2 endothelin 2 x x x
S100P S100 calcium binding protein P x x
CRIP1 cysteine-rich protein 1 (intestinal) x x x
TSC22D2 TSC22 domain family, member 2 x x
NTF3 neurotrophin 3 x x x
TRIP13 thyroid hormone receptor interactor 13 x x x
KLF2 Kruppel-like factor 2 (lung) x x x
IQGAP3
IQ motif containing GTPase activating
protein 3
x x x
AXL AXL receptor tyrosine kinase x x
PRC1 protein regulator of cytokinesis 1 x x
PMP22 peripheral myelin protein 22 x x
GBP3 guanylate binding protein 3 x x
CDC42EP3
CDC42 eector protein (Rho GTPase
binding) 3
x x x
ASPM
asp (abnormal spindle) homolog,
microcephaly associated (Drosophila)
x x x
CEP55 centrosomal protein 55kDa x x
DUSP1 dual specicity phosphatase 1 x x
OXTR oxytocin receptor x x x
TIPARP
TCDD-inducible poly(ADP-ribose)
polymerase
x x x
CA12 carbonic anhydrase XII x x
RPL29 ribosomal protein L29 x x
UBXN1 UBX domain protein 1 x x
* x in column 3 indicates predicted binding sites for SREBP in human and in columns 4 and 5 conserved
predicted SREBP binding sites in chimp and mouse, respectively.
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Symbol Gene Name Predicted* Chimp* Mouse*
GADD45B
growth arrest and DNA-damage-inducible,
beta
x x x
* x in column 3 indicates predicted binding sites for SREBP in human and in columns 4 and 5 conserved
predicted SREBP binding sites in chimp and mouse, respectively.
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